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Abstract 
The dopamine neurotransmitter is present in all multicellular organisms. In the 
brain, the dopaminergic system orchestrates reward-motivation pathways and is 
involved in the control of voluntary movements and endocrine hormone secretion. 
Dysfunction of dopamine signalling may lead to pathological conditions such as 
Parkinson’s disease, where dopaminergic neurons of the midbrain degenerate. 
Moreover, modulation of dopamine receptor signalling influences tumour growth. 
The aim of this work was to explore the regeneration capacity of the dopaminergic 
system in the vertebrate brain and to test whether dopamine may control the 
growth of brain tumours. To this end we performed two sets of studies. Initially, we 
investigated the development and regeneration of the dopaminergic system in 
newts, which are aquatic salamanders capable of complete regeneration of the 
dopaminergic system in the brain. Thereafter, we investigated how dopaminergic 
ligands impinge specifically on brain tumour cells. 
In paper I, we screened a library of dopaminergic ligands for their ability to 
stimulate or to inhibit glioblastoma cell growth and survival. We identified the 
dopamine receptor 2 antagonist, trifluoperazine, as an inhibitor of glioblastoma 
growth. We also showed that susceptibility to trifluoperazine correlates with the 
dopamine receptor expression profile of the investigated glioblastoma cell lines. 
We concluded that dopamine receptor signalling pathways are promising targets 
for pharmacological interventions to inhibit glioblastoma growth. 
In paper II, we characterized the cellular basis of brain development and 
stereotyped behaviour in two regeneration model salamander species. These data 
provide insight into the maturation of neural stem cells that are found in the adult 
salamander brain. Furthermore, we showed how lesioning of the dopaminergic 
innervation affects neurogenesis in the forebrain and behavioural performance. 
This study provides a new evolutionary perspective on the genesis and dynamics 
of brain cells in the salamander brain, including dopaminergic cells. 
In paper III, we developed a tissue clearing method, CUBICe, to extend our study 
of dopaminergic neurite outgrowth during development as well as regeneration. 
We demonstrated that CUBICe is compatible for high resolution imaging of whole 
salamander brains. It is also a faster and more robust method, which allows to 
maintain a better sample integrity of embryonic brains in general, compared to 
Advanced CUBIC and Advanced CLARITY. In addition, using CUBICe we achieved 
tracing of genetically marked cells with neurite outgrowth of over 3600 µm. 
Ultimately, we showed that our method is ideal for tracing genetically marked 
dopaminergic cells in the salamander brain and for quantifying dopaminergic 
neurite density and regeneration in whole brain regions. In summary, this thesis 
provides insight into the versatile role of dopamine in both normal and pathological 
conditions of the vertebrate brain, as well as offers innovative tools for studying 
the regeneration of the dopaminergic system.
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1. Introduction 
“We all woke up this morning and we had with it the amazing return of our 
conscious mind. We recovered minds with a complete sense of self and a 
complete sense of our own existence — yet we hardly ever pause to consider this 
wonder.” 
António Damásio1 
The brain... comprised of 86 billions of neurons and another 85 billions of other 
brain cells (Farfel et al., 2009), interconnected and working together to bring about 
our conscious mind. What a marvellous structure! Between 400,000-600,000 of 
these cells are dopaminergic neurons in humans (Björklund & Dunnett, 2007), a 
tiny fraction of the overall picture and yet, so critical for maintaining correct brain 
function. More than 70% of these neurons are located in the substantia nigra, a 
small brain region that suffers severe neurodegeneration in Parkinson’s disease 
(Björklund & Dunnett, 2007; Höglinger et al., 2004; Winner & Winkler, 2015). This 
level of degeneration of these dopaminergic neurons is correlated with the degree 
of motor movement deficiencies observed in Parkinson patients. The human brain 
has limited capacity for regeneration, illustrated by its incapacity to recover from 
dopaminergic degeneration. The reasons behind this are unclear. Perhaps it has 
something to do with brain complexity, brain size or a higher degree of 
specialization of its constituent cells during embryonic development. The historical 
case of Phineas Gage, a man who suffered severe brain injury by a metal rod which 
crossed through his skull and brain (Ratiu, Talos, Haker, Lieberman, & Everett, 
2004), has shown us the human brain’s remarkable focus on damage control. By 
this I refer to brain plasticity, the capacity of some brain regions to replace the 
functions of other injured areas. From my perspective, this is a rather limited 
mechanism and is far from a full regeneration response where the lost cells would 
actually be replaced. Some organisms, such as salamanders, possess a much 
greater repertoire of regenerative capacities than humans. Only through the 
mechanistic understanding of the cellular and molecular regenerative processes 
in these animals can we try to elicit a similar regeneration potential in humans. 
Perhaps the regeneration potential of the human brain too lies quiescent, with its 
cellular mechanisms waiting to be unlocked.  
The neurotransmitter, dopamine, is one of the regulating components of 
regeneration in the salamander brain. Indeed, its absence leads to activation of 
progenitor cells in the midbrain and subsequent regeneration of an injured 
dopaminergic population. Dopamine is also present in all known multicellular 
                                                   
1 “Self Comes to Mind: Constructing the Conscious Brain” (2012), ISBN: 978-0099498025. 
 
 
2 
organisms (Barron, Søvik, & Cornish, 2010; Berg, Belnoue, Song, & Simon, 2013), 
providing further support for its biological importance. Moreover, its functions go 
far beyond neurotransmission and the regulation of regeneration. Dopamine has 
been shown to be involved in development, by controlling the proliferation of cells 
which later give rise to different brain functions and behaviours (Freundlieb et al., 
2006). Dopamine agonists and antagonists have been shown to regulate cancer 
progression (Rubí & Maechler, 2010) and dopamine has been found to be involved 
in the progression of Parkinson’s disease, as previously mentioned in the 
beginning of this chapter. In the case of cancer, dopamine signalling has been 
shown to be involved in the regulation of cancer growth (Dolma et al., 2016).  
The present work provides insight into the versatile role of dopamine in 
development, regeneration and disease. Furthermore, it provides tools for 
studying the regeneration of the dopaminergic system. 
In the words of Emerson Pugh2, “if the human brain were so simple that we could 
understand it, we would be so simple that we couldn’t”. Studying the brain is an 
immeasurable challenge and it can be argued that progress in this research field 
occurs at a somewhat slower pace compared to others. However, we can only try 
(and hopefully succeed). 
1.1. Aims 
In order to explore how modulation of dopamine signalling could be used in future 
clinical therapies, we need to understand its action, the extent of its effects and to 
have the right tools for its study. 
The overall aim of this thesis was to progress the understanding of dopamine’s 
functions in the contexts of development, regeneration and disease, departing 
from the paradigm of dopamine’s control of regenerative processes in the 
salamander brain (Fig. 1; Berg, Kirkham, Wang, Frisén, & Simon, 2011). 
Specific aims for the scientific papers I-III were: 
I. To evaluate the capacity of dopamine signalling to inhibit glioblastoma 
proliferation and survival. 
II. To provide an evolutionary perspective on the development of the 
vertebrate brain and associated behaviours, with a focus on the 
dynamics of dopaminergic neurogenesis. 
III. To develop methods for the study of both the neurite outgrowth of 
dopaminergic neurons and also the fibre projections of ependymoglial 
                                                   
2 ”Biological Origin of Human Values” (1978), ISBN: 978-0710089250. 
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cells (the progenitors of dopaminergic cells). To undertake this in a 
regeneration and development setting in the newt brain. 
 
Figure 1 | Dopamine’s involvement in the three papers of this thesis as well as in their 
respective fields: disease, development and regeneration.  
1.2. Thesis content 
Both papers II and III included in this thesis utilize the newt, a subfamily of 
subaquatic salamanders, as an animal model. To understand the importance of the 
newt as a regeneration model organism, I discuss its advantages in Chapter 2. In 
Chapter 3, I examine the differences between stem and progenitor cells as well as 
how to distinguish these cell types from each other. All the papers in this thesis 
study the effects of dopamine or the dopaminergic system, and all of these studies 
stemmed from observations of the unique neurogenic capacity of the adult newt 
after dopaminergic lesion. In Chapter 4 I allude to the neurogenic differences 
between humans, rodents and newts. In paper II I attained the need for better 
methods to study the development and regeneration of dopaminergic neurites in 
the newt brain, which gave rise to paper III. In Chapter 5 I discuss the 
methodological background that was the genesis for the CUBICe method 
development (paper III). In Chapter 6 I discuss fundamentals of cancer biology, 
which gave rise to our hypothesis that dopamine is a player in a type of brain 
cancer, glioblastoma (paper I). In Chapter 7, I discuss the background studies of 
dopamine that bring papers I-III together: dopamine’s involvement in 
development, regeneration and disease. In Chapter 8, I summarize and discuss the 
results of papers I-III, as well as presenting some of their limitations. 
Dopamine 
Disease 
Inhibition of 
glioblastoma cell 
growth by a 
dopaminergic ligand 
 
Development 
The origin of neural 
stem cells and 
dopaminergic neurons 
 
 
Regeneration 
Methods for the study 
of dopaminergic 
neurite regeneration 
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2. The newt: a versatile 
animal model 
The species of salamanders studied in papers II and III, Notophthalmus viridescens 
(North American) and Pleurodeles waltl (Iberian), are newts (Fig. 2; J. Brockes & 
Kumar, 2005). Cynops pyrroghaster (Japanese) is another species of newts which 
is commonly used in research laboratories (Fig. 2). Newts belong to the subfamily 
Pleurodelinae of aquatic salamanders and are part of the class Amphibia as well 
as the superclass of tetrapods. Urodeles, also known as Caudata, is the order 
containing all salamanders and is characterized by the presence of tail in the adult 
(Laudet, 2011). Newts are a subfamily of urodeles/salamanders, which can be 
distinguished from other salamanders by their aquatic life in adulthood (J. Brockes 
& Kumar, 2005), while other salamanders are mostly terrestrial. 
 
Figure 2 | Phylogenetic positions of Notophthalmus, Pleurodeles, Cynops and 
Ambystoma among the tetrapod superclass. 
To reach adulthood newts go through three developmental phases: larval, 
terrestrial juvenile and aquatic adult  (J. Brockes & Kumar, 2005; Joven, Kirkham, 
& Simon, 2015). These developmental phases were used as research models in 
papers II and III. During the larval phase, newts undergo metamorphosis, which is 
considered to be a rather dramatic postembryonic developmental process, where 
abrupt morphological changes occur (Reiss, 2002). Among non-extinct 
amphibians, frogs, salamanders and caecilians demonstrate distinct metamorphic 
capacities. These morphological changes have three bases aimed at functional 
adaptation: (i) environmental – a switch from water to land/air (ii) locomotional – a 
switch from swimming to hopping (iii) feeding – a switch from feeding on water-
suspended food to predation. However, in newts, metamorphosis is a rather mild, 
less dramatic process, when compared to frogs. This is especially so when 
considering newts do not undergo environmental functional adaptation through 
metamorphosis: they remain living an aquatic life after adulthood instead of 
(newts) 
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switching to a terrestrial habitat. Generally, metamorphosis in the newt involves the 
reabsorption of the gills and the development of the limbs (Cameron, Beug, & 
Tsilfidis, 2004). During juvenile to adult phases, newts become sexually mature. 
Another species of salamanders commonly used in research laboratories is the 
axolotl, Ambystoma mexicanum (Fig. 2). This species is often incorrectly identified 
as a newt due to its aquatic life. Instead, the aquatic characteristics of the axolotls 
are due to paedomorphosis, where it retains the larval characteristics in the adult 
form (Laudet, 2011). The axolotl is extensively used in limb regeneration studies. 
Interestingly, rather different cellular and molecular mechanisms are involved in 
limb regeneration in the axolotl, when compared to the newt (Sandoval-Guzmán et 
al., 2014). 
Among vertebrates, newts display the largest repertoire of regenerative capacities 
in adulthood (Tsonis & Fox, 2009). Additionally, their evolutionary proximity to 
mammals make them ideally suited for the cross-species study of the basal 
foundations of their regenerative capacities (Laudet, 2011). Newts are able to 
regenerate the heart (Oberpriller & Oberpriller, 1974; Witman, Murtuza, Davis, 
Arner, & Ian, 2011), limbs (J. P. Brockes, 1997), spinal cord (Davis, Ayers, Koran, 
Anderson, & Simpson, 1990), lens (Eguchi, 1988), brain (Parish, Beljajeva, Arenas, 
& Simon, 2007), male but not female gonads (Scadding, 1977), tail (Iten & Bryant, 
1976), intestine (O’Steen, 1958) and jaw (Goss & Stagg, 1958). Interestingly, the 
kidney has been reported as a structure not capable of regeneration in the newt 
(Scadding & Liversage, 1974). The capacity for brain regeneration in newts is 
discussed in detail in Chapter 7. 
A striking feature of newt regeneration is its independence of age and successive 
number of injuries. Such findings were demonstrated in a series of experiments 
spanning 30 years, where some animals underwent 17 consecutive rounds of lens 
removal and subsequent regeneration episodes, without any sign of regenerative 
decline in terms of pace, morphology, or gene expression pattern (Eguchi et al., 
2011). 
The dopaminergic innervation pathways of the basal ganglia, such as the midbrain-
to-striatum pathway studied in papers II and III, are highly conserved in tetrapods 
(O Marín, Smeets, & González, 1998). Taken together, the evolutionary proximity to 
mammals, the capacity for regeneration of dopaminergic cell subpopulations and 
the high degree of conservation of the dopaminergic midbrain-to-striatum pathway 
make newts an ideal animal model for the mechanistic understanding of the 
dopaminergic system’s regeneration (Laudet, 2011; O Marín et al., 1998; Parish et 
al., 2007). 
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3. Of stem and 
progenitor cells 
The concepts of stem and progenitor cells are sometimes used ambiguously, 
which can lead to confusion (Seaberg & Van Der Kooy, 2003). 
The concept of stem cell properties derives from studies by McCulloch and Till, 
who first demonstrated transplanted mouse marrow cells could proliferate and 
form colonies in the spleen of irradiated mice (Becker, McCulloch, & Till, 1963). This 
finding added to the then existing model of haematopoiesis, which assumed blood 
cells would arise from progenitor cells with proliferation capacity. Based on these 
studies, it was then suggested hematopoietic tissue would have a hierarchical 
structure, composed of progenitor cells, cells with limited capacity for division and 
fully differentiated cells. At the same time, the concept of stemness, the unique 
characteristics of what defines a stem cell, was proposed (Becker et al., 1963; 
McCulloch, Minden, Miyauchi, Kelleher, & Wang, 1988; Seaberg & Van Der Kooy, 
2003). Currently, these characteristics are: (i) long-term capacity for division and 
self-renewal; (ii) an undifferentiated state; (iii) capacity to give rise to differentiated 
cell types (Bethesda, 2016). 
Stem cells can be classified according to different degrees of potency (Banerjee, 
2011): (i) totipotent – capable of giving rise to complete embryos and the extra 
embryonic tissue; (ii) pluripotent – capable of giving rise to every cell type in the 
body; (iii) multipotent – capable of giving rise to multiple cell types in a given tissue; 
(iv) unipotent – capable of giving rise to only one cell type in a given tissue.  
Stem cells can also be classified according to their origin (Banerjee, 2011): (i) 
pluripotent embryonic stem cells (ESCs); (ii) multipotent or unipotent adult stem 
cells (ASCs); (iii) cancer stem cells (still a hypothesis, as explained in Chapter 6); (iv) 
induced pluripotent stem cells (iPSCs), where the term “induced” refers to the fact 
that these cells are genetically or chemically reprogrammed to become stem cells 
from adult somatic cells. Pluripotent ESCs can give rise to any of the three 
embryonic germ layers: ectoderm, mesoderm and endoderm. From each of these 
layers, different lineages of ASCs are derived, which in its turn give rise to cell types 
belonging to each of the specific tissues in the body (e.g. pancreatic or neural 
tissue).The concept of stem cell has been blurred by the discovery of stem cell 
plasticity, a concept that implicates different types of stem cells in the crossing of 
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lineage boundaries to give rise to tissue belonging to different germ layers than 
the one they originate from (Blau, Brazelton, & Weimann, 2001).  
Progenitor cells are an intermediate state in the differentiation path from stem cell 
to differentiated cell, and can be in an undifferentiated or partly differentiated state 
(Bethesda, 2016). Stem cells can be distinguished from progenitor cells by 
functional assays (Seaberg & Van Der Kooy, 2003). However, the assessment of 
these functional characteristics can be challenging, either in vitro or in vivo. Stem 
cells can divide symmetrically to give rise to either two other stem cells with 
capacity for self-renewal or two progenitor cells with no capacity for self-renewal 
but with proliferative capacity. Alternatively, stem cells can divide asymmetrically 
and generate one stem cell and one progenitor cell. 
In vitro, it is possible to assess if a cell has stem properties. However, assessing 
proliferation of cells alone is not evidence of being a stem cell, as different kinds 
of progenitor cells are also capable of proliferation. In fact, being proliferative does 
not even imply capacity for self-renewal (Clarke et al., 2006). To assess the 
functional characteristics of stem cells in vitro, one can evaluate if the cell 
proliferates and track its progeny to check whether specialized cell types are 
formed. Thus, indicating multipotentiality or unipotentiality.  
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4. Neurogenesis 
Neurogenesis is defined as the production and functional integration of new 
neurons. In the adult brain, neurogenesis is fuelled by neural stem/progenitor cells 
(NSPCs), which are located in discrete neurogenic niches. The mammalian adult 
brain displays a limited neurogenic potential and this could explain the inability of 
mammals to regenerate neurons lost after stroke-injuries or during the 
development of neurodegenerative diseases. A wide variation in the extent of 
adult neurogenesis is seen among species, and this variation correlates with 
habitat and absolute age (Amrein, 2015). Specifically, rodents living in 
environmentally challenging habitats were shown to have higher adult 
hippocampal neurogenesis than rodents living in protected environments (Amrein 
et al., 2014). Furthermore, cell proliferation decreases with age in the hippocampus 
of rodents in both environmentally challenging and protected habitats (Amrein et 
al., 2014; Amrein, Isler, & Lipp, 2011a; Cavegn et al., 2013). While such variation 
represents a difficulty for the development of a common mechanistic 
understanding of neurogenesis, it also represents an opportunity to extend the 
limited regenerative capacity of the mammalian brain. This might be achieved 
through the understanding of neurogenesis in various species followed by the 
developing of methodological approaches to elicit neuron regeneration in the 
species where this capacity is lacking. 
4.1. In humans 
The cellular composition of the adult human brain has long been viewed as static. 
This is partly because research on the birth of new neurons has been undertaken 
more intensively in rodent models than in humans due to methodological 
limitations. However, we know today that neurogenesis also occurs in the human 
brain (Eriksson et al., 1998; Spalding, Bhardwaj, Buchholz, Druid, & Frisén, 2005). 
NSPCs have been found in two neurogenic niches: in the subventricular zone (SVZ) 
of the lateral ventricles and in the dentate gyrus (DG) of the hippocampus (Fig. 3; 
Braun & Jessberger, 2014). These findings were based on the expression of 
neuroblast markers and cell morphology (Frisén, 2016). Moreover, neuroblasts 
were deemed to decrease in numbers after the initial post-natal weeks, potentially 
explaining the limited regenerative capacity observed in the adult human brain 
(Göritz & Frisén, 2012). Neurogenesis has also been reported to occur in a third 
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neurogenic niche, the human striatum (Fig. 3). However, the source of these new 
neurons is still debated and is discussed later in this chapter (Ernst et al., 2014). 
 
Figure 3 | Neurogenic niches in the human 
brain: DG, SVZ and striatum. Adapted from 
Braun & Jessberger, 2014. 
The first evidence for neurogenesis in the adult human brain was the finding of the 
incorporation of a nucleotide analogue, Bromodeoxyuridine (BrdU), in the cells in 
the DG of post mortem brains from patients with head and neck cancer (Eriksson 
et al., 1998). Here, BrdU was administered for diagnostic purposes. Since then, the 
development of a method to date cell birth based on the levels of carbon-14 in 
genomic DNA has paved the way to new insights into adult human neurogenesis 
(Spalding et al., 2005). 
* Dentate gyrus of the hippocampus 
In the DG of the hippocampus, two populations of neurons are known to exist. In 
one population, no cell turnover has been detected, while the other population has 
a median annual turnover of 1.75% (Spalding et al., 2013). This rate modestly 
declines with age in humans, while in rodents it declines more emphatically from 
young to old age (Ben Abdallah, Slomianka, Vyssotski, & Lipp, 2010). In mice, 
during the hippocampal neurogenic process, a subpopulation of about 10% of the 
dentate granule neurons are replaced throughout adulthood (Fig. 4; Imayoshi et 
al., 2008; Ninkovic, Mori, & Götz, 2007). In contrast, all of the dentate granule 
neurons are thought to be replaced during adulthood in humans (Fig. 4; Bergmann, 
Spalding, & Frisén, 2015; Spalding et al., 2013). While the functional relevance of 
hippocampal neurogenesis in mice has been correlated with pattern separation in 
memory formation and cognition, evidence for the same functions in humans are 
still lacking (Bergmann et al., 2015). 
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Figure 4 | Proportion of dentate granule neurons replaced throughout the lifetime 
of mice and humans. While in humans virtually all of these neurons are replaced 
throughout life, in mice this proportion accounts for only 10%. Adapted from Ernst 
et al., 2014. 
* Subventricular zone of the lateral ventricle walls 
Another neurogenic niche in the adult human brain is the SVZ in the walls of the 
lateral ventricles. Whether NSPCs give rise to migratory neuroblasts that travel to 
the human olfactory bulb is controversial. Upon studying of the identity of the 
NSPCs in the human SVZ, Sanai and colleagues have shown a ribbon of astrocytes 
lining the lateral ventricles which express glial fibrillary acid protein (GFAP) and 
vimentin (Sanai et al., 2004). Contrary to the situation in mice, the same study has 
found no evidence for neuroblast migration. However, in the forebrain of human 
foetal samples, another study reported substantial proliferation and migrating 
neuroblasts expressing doublecortin (DCX) in the human SVZ (C. Wang et al., 2011). 
The DCX expression in the SVZ was confirmed by another study performed with 
infant human brain samples (Sanai et al., 2011). Curtis et al. argued that a rostral 
migratory stream (RMS) exists in humans, through which neuroblasts migrate to the 
olfactory bulb (Curtis et al., 2007). However, the measurement of the proliferating 
cell nuclear antigen (PCNA) in this study, as a proliferation marker of neuroblasts, 
did not correlate with the expression of ki-67 and MCM2 markers used in similar 
studies (Sanai et al., 2004; C. Wang et al., 2011). These findings indicate PCNA 
might not be specific to proliferating cells in the human brain (as reviewed in 
Bergmann 2015). An eventual neuronal turnover in the olfactory bulb of adult 
humans would indirectly argue for the existence of the RMS. Yet, the turnover rate 
of these neurons has been reported to have an exchange rate of less than 1% in 
100 years, a striking contrast to the 50% annual exchange rate seen in rodents 
(Bergmann et al., 2012; Imayoshi et al., 2008). Taken together, the existence of 
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migrating neuroblasts from the human SVZ and of a human RMS remain elusive. It 
is therefore unclear what the fate of the neuroblasts found in SVZ may be, 
especially considering the absence of apoptosis (Ernst et al., 2014).  
* Striatum 
As opposed to mice, neurogenesis has been reported to also occur in the human 
striatum (Ernst et al., 2014). Both protein and transcriptomic interrogations 
demonstrated that the neuroblast marker DCX is present in the striatum with 
expression levels comparable to the human hippocampus. Additionally, striatal 
interneurons were shown to be born in the adult brain of cancer patients who had 
been administered with a thymidine analogue for diagnostic purposes (Ernst et al., 
2014). Furthermore, a turnover rate of 2.7%/year was found in the DARP23- 
interneuron subpopulation in the striatum, indicating that new interneurons are 
formed through neurogenesis in the striatum (Bergmann et al., 2015; Ernst et al., 
2014). Whether these newly born interneurons originate from the SVZ is unclear. 
Contrary to this theory, in another study performed in mice, parenchymal 
astrocytes have been found to give rise to striatal neurons post stroke, opening 
new possibilities for the role of astrocytes in striatal neurogenesis (Magnusson et 
al., 2014). Indeed, the proposed roles of the striatum in motor function and 
cognitive flexibility would argue for the occurrence of striatal neurogenesis 
throughout adulthood (Ernst & Frisén, 2015). 
* Neurogenesis after acute brain injury - ischemic stroke 
Despite the presence of NSPCs in humans, brain regeneration is not known to 
occur after injury, and our capacity to halt neurodegeneration is modest. However, 
an increase in cell proliferation was found after ischemic stroke in the ipsilateral 
SVZ, raising questions on the existence of a neurogenic response after injury 
(Marti-Fabregas et al., 2010). Additionally, preliminary data on the age of striatal 
neurons in human samples with ischemic stroke has shown likelihood for two 
possibilities: either there is increased neurogenesis in the striatum after striatal 
stroke or there is selective death of old neurons compared to young neurons 
(Magnusson, 2017). The answer could also be explained by a combination of the 
two possibilities. Although stroke patients can show some signs of recovery, 
months or even years after stroke, the mechanism currently believed to be 
responsible for this is brain plasticity rather than neurogenesis (Nudo, 2013).  
* Neurogenesis after chronic brain damage - Parkinson’s disease 
In the case of chronic pathological conditions, such as Parkinson’s disease (PD), 
where patients do not regenerate lost dopaminergic neurons in the midbrain, 
humans once again show limited capacity for brain regeneration. However, one 
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study has found expression of a marker of immature migrating neuroblasts, the 
polysialylated neuronal cell adhesion molecule (PSA-NCAM). This finding is 
indicative of activation of resident glial cells, which are known to also express PSA-
NCAM (Arias-Carrión, Freundlieb, Oertel, & Höglinger, 2007; Nomura, Yabe, 
Rosenthal, Krzan, & Schwartz, 2000; Yoshimi et al., 2005). This process could be 
the first step to an incomplete neurogenic response. The involvement of dopamine 
and neurogenesis in PD is further discussed in Chapter 7. 
* Cell replacement therapies 
Cell replacement therapies hold great promise towards the replacement of the lost 
cells after brain injury, though success in human trials has been limited (Lindvall, 
Kokaia, & Martinez-Serrano, 2004). In principle, there are two main routes for cell 
replacement therapy, involving the use of endogenous or exogenous cell sources 
(Grade & Götz, 2017). In an endogenous approach, the NSPCs in the DG and SVZ 
neurogenic niches, or the latent local progenitors can be induced to expand and 
differentiate, and possibly to migrate, to replace a lost cell type at an injury site. For 
instance, astrocytes have been successfully induced to enter a neurogenic 
program by blocking of notch signalling in the striatum of mice (Magnusson et al., 
2014). Another way to pursue an endogenous approach is to reprogram brain cells 
close to the injury site  to the lost cell type, using either transcription factors or 
small molecules (Pfisterer et al., 2016; Takahashi et al., 2007). Exogenous 
approaches involve the transplantation of committed or differentiated donor cells 
to the injury site, with the aim of replacing lost cells. In this approach donor cells 
can be foetal neurons, embryonic neural stem cells (eNSCs), embryonic stem cells 
(ESCs) or induced pluripotent stem cells (iPSCs). The use of foetal neurons for cell 
replacement therapies has already been applied in Parkinson’s disease patients 
with variable results. The start of the first pluripotent stem cells (PSC) human trials 
in Parkinson patients is imminent. These findings are further discussed in Chapter 
7. 
4.2.In rodents 
In rodents, the two most extensively studied neurogenic niches are the SVZ of the 
lateral ventricles and the DG of the hippocampus (Fig. 5; Braun & Jessberger, 
2014). NSPCs are mostly in a quiescent state in the SVZ and DG, but upon 
activation by internal or external signals, they undergo proliferation and 
differentiation into new neurons, followed by maturation and integration into 
axonal networks in their surroundings (Braun & Jessberger, 2014; Chunmei Zhao, 
Deng, & Gage, 2008). 
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Figure 5 | Neurogenic niches in the mouse brain: DG, SVZ and 
Hypothalamus. Adapted from Braun & Jessberger, 2014. 
* Dentate gyrus of the hippocampus 
In the DG of the hippocampus, new neurons are generated by radial NSPCs, also 
called radial-glia-like cells. These are activated to produce numerous non-radial 
NSPCs, thereby increasing the number of cells with neurogenic capacity. These 
cells become immature neurons and migrate to the granule cell layer where they 
integrate their projections in the hilus and area 3 of cornu ammonis, thereby 
becoming granule neurons (Toni et al., 2008; C. Zhao, 2006). One of the functions 
of the neurogenic process in the DG is believed to be the pattern separation in 
learning and memory (Sahay, Wilson, & Hen, 2011). Interestingly, cell proliferation 
in the hippocampus declines with age. Studies in both wild and laboratory 
mammals indicate that this decline is similar across several species, independent 
of the ontogenetic rate and correlated with absolute age (Amrein, 2015; Amrein, 
Isler, & Lipp, 2011b). However, the levels of actual hippocampal neurogenesis have 
been reported to differ based on the original habitats of a pool of 11 rodent species. 
Here, mole-rats with subterranean habitats and relatively stable habitats show 
lower levels of hippocampal neurogenesis than southern African mice living in dry 
demanding climates (Amrein, 2015; Amrein et al., 2014; Cavegn et al., 2013). Such 
findings argue for a role of hippocampal neurogenesis in behavioural flexibility. In 
accordance with a role of the surrounding environment in the regulation of the 
neurogenic process, physical exercise in the form of running has been shown to 
increase neurogenesis in the dentate gyrus of the hippocampus (Van Praag, 2008). 
Furthermore, such variations in neurogenesis levels between species highlight the 
need for undertaking cross-species studies before generalization of the dynamics 
and cellular processes involved in neurogenesis. 
* Subventricular zone of the lateral ventricle walls 
In another neurogenic niche in mice, the SVZ of the lateral ventricle, neurogenesis 
occurs in two phases. First, type B NSPCs, also called radial-glia like cells, are 
activated to produce non-radial type C NSPCs with neurogenic capacity. These 
SVZ
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cells become immature neurons (type A neuroblast cells) and migrate to the 
olfactory bulb through the rostral migratory stream (RMS). Then, upon arrival to the 
olfactory bulb, neuroblasts differentiate to produce interneurons (Braun & 
Jessberger, 2014; Kempermann, Jessberger, Steiner, & Kronenberg, 2004; Merkle 
& Alvarez-Buylla, 2006). During this process, about 40% of the maturated neurons 
integrate and survive for up to 19 months (Winner, Cooper-Kuhn, Aigner, Winkler, 
& Kuhn, 2002). 
* Hypothalamus 
Several studies have reported neurogenesis to occur in the hypothalamus of 
rodents (Kokoeva, 2005; Pierce & Xu, 2010). One of the progenitor cell sources in 
this neurogenic process is believed to be the β2-tanycyte population, a type of 
radial glia-like ependymal cells at the base of the third ventricle of the hypothalamic 
median eminence (D. A. Lee et al., 2012). These cells have been shown to give rise 
to new born neurons which express mature hypothalamic neuron markers such as 
GAD6, MAP2, NPY, POMC and c-fos (D. A. Lee et al., 2012). The functions of 
hypothalamic neurogenesis are still under interrogation. Interestingly, mice fed 
with a high-fat diet had 4-fold higher neurogenesis than the controls, 
demonstrating the effect of dietary changes in adult hypothalamic neurogenesis 
(D. A. Lee et al., 2012).  
* Molecular regulation of adult neurogenesis 
Transcriptional regulators are involved in the regulation of the neurogenic process 
in the SVZ and the DG. These are Prox1, Sox2, NeuroD1, Ascl1, Pax6, Gsx2, Sp8, 
Prox1 and TLX (Braun & Jessberger, 2014; Chunmei Zhao et al., 2008). 
Interestingly, neurotransmitters have also been shown to control adult 
neurogenesis in the SVZ and DG, implicating neurotransmitter signalling into 
broader brain functions than the signal transmission between neurons (Berg et al., 
2013). These neurotransmitters are acetylcholine, dopamine, GABA, glutamate, 
nitric oxide, neuropeptide Y, noradrenaline and serotonin. In Chapter 7 the role of 
the neurotransmitter dopamine in brain regeneration in connection with 
neurogenesis is further discussed. The literature on the molecular regulation of 
adult neurogenesis is vast. Besides the regulation exerted by neurotransmitters 
and transcription factors, several proteins and hormones also play a role (Egeland, 
Zunszain, & Pariante, 2015; Guillemot, 2005; Hagg, 2005; H. Liu & Song, 2016). 
* Neurogenesis after ischemic stroke 
Rodents show some capacity for adult neurogenesis after ischemic stroke. In rats, 
a study shows that ischemic stroke in the striatum induces neurogenesis of 
cholinergic and GABAergic neurons, which become functionally integrated (S. W. 
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Hou et al., 2008). In gerbils, an increased neurogenesis was detected in the 
dentate gyrus post ischemic stroke, which is shown by newly generated cells 
expressing neuronal markers such as calbindin-D28K, microtubule-associated 
protein-2 and neuronal nuclear antigen (J. Liu, Solway, Messing, & Sharp, 1998). 
Although rodents seem to show a higher capacity for neurogenic-based 
regeneration after ischemic stroke than humans this is still modest and does not 
lead to full recovery. The lack of studies in humans maybe misleading, thus there 
might also be an eventual neurogenic response after stroke, similar to the one 
observed in rodents. 
4.3. In newts 
Newts exhibit the most extensive regenerative capacity among vertebrates, as 
previously discussed in Chapter 2. Parish and colleagues examined the 
regenerative/neurogenic ability of the adult newt brain, Notophthalmus 
viridescens, by using a cell type-specific chemical ablation injury model, which 
resembles a Parkinson-like animal model (Parish et al., 2007). This ablation was 
performed with 6-hydroxydopamine (6-OHDA), which is a neurotoxin that 
selectively ablates catecholaminergic neurons and is used in the creation of other 
parkinsonian animal models. Here the authors have shown that, after selective 
ablation of dopaminergic neurons in the ventral midbrain, a neurogenic program 
was natively initiated. This lead to full regeneration of the lost neuronal population 
as well as reacquisition of normal motor performance. These findings demonstrate 
that that the adult vertebrate brain is capable of regulating its neurogenic 
regenerative potential by activation and deactivation of quiescent regions, such as 
the ventral midbrain in the newt. A more detailed discussion on the role of 
dopamine in neurogenesis is provided in Chapter 7. 
The regeneration of dopaminergic neurons in the ventral midbrain of the newt is 
fuelled by ependymoglial cells, which line the lateral ventricle and express GFAP 
(Berg et al., 2010). Due to the lack of astrocytes in the newt brain this is the only 
cell type expressing GFAP (Benraiss, Arsanto, Coulon, & Thouveny, 1999; Lazzari, 
Franceschini, & Ciani, 1997). In the newt telencephalon, ependymoglial cells have 
been found to be of two types (Kirkham, Hameed, Berg, Wang, & Simon, 2014): 
Type-1 are stem-cell-like, GFAP+ and glutamine synthetase (GS)+, and are the main 
quiescent; Type-2 are transit-amplifying-progenitor-like, GFAP+ and GS-, and 
correspond to the majority of the proliferating GFAP+ cells in activate neurogenic 
regions of the brain or the so called “hotspot regions”. Interestingly, after 
cholinergic ablation, mainly quiescent regions of the brain, “non-hotspots”, 
became more active. This was shown by the proliferation of type-2 cells and PSA-
NCAM+ cells which could now be found in these previously quiescent regions. PSA-
NCAM is a marker of immature migrating neuroblasts (Arias-Carrión et al., 2007; 
Nomura et al., 2000; Yoshimi et al., 2005). Taken together, the dynamics of type-
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1, type-2 and PSA-NCAM+ cells upon cholinergic lesion suggest an orchestrated 
neurogenic process in both regions of active neurogenesis and regions that were 
previously quiescent in the newt brain.  
Another study has shown that accumulation of reactive oxygen species (ROS) is 
required for ependymoglial cell activation as well as subsequent neurogenesis 
(Hameed, Berg, Belnoue, & Jensen, 2015). Furthermore, ROS was specifically 
shown to be necessary for the regeneration of the ventral midbrain dopaminergic 
neurons after lesion. 
In paper II, we aimed to further characterize the mechanisms behind the brain 
regenerative capacity in the newt. To this end, we studied the basis of cellular brain 
development in two newt species, Pleurodeles waltl and Notophthalmus 
viridescens. We described the regional peaks of neurogenesis throughout 
development and correlate it with the acquisition of stereotypical behaviours. We 
also found that injury-induced lack of dopaminergic innervation in the striatum 
decreased proliferation in the brain of Pleurodeles waltl. Such findings gave rise to 
the hypothesis that a mechanism of striatal neurogenesis is controlled by 
dopaminergic midbrain-to-striatum fibres. 
In summary, newts possess a native brain regeneration capacity and an ability to 
activate their quiescent cells to an extent that has not been observed in 
mammalian brains. The understanding of such processes could represent an 
important contribution towards developing native regeneration therapies for brain 
injuries. 

 19 
5. Tissue clearing methods 
for the brain 
Tissue clearing methods facilitate the imaging of whole brain volumes without the 
need for mechanical sectioning and preserve structural relationships between the 
components of a sample. These advantageous features are especially useful for 
neurite or fibre tracing studies. Generally, whole-structure imaging methods, such 
as magnetic resonance imaging (MRI), stand as an alternative to the mechanical 
sectioning of samples. In fluorescent or light microscopy, however, imaging deep 
into the tissue is largely limited by light scattering, caused by the different phases 
of water and organic compounds within the sample, which result in a variable 
refractive index (RI) throughout the tissue. These variations bend the light and 
make the tissue opaque. In order to achieve transparency and, in consequence, 
deep tissue imaging, one needs to homogenize these RI variations. In biological 
samples, lipids are one of the main sources of light scattering. Hence, the removal 
of lipids is at the basis of achieving tissue transparency. In essence, many tissue 
clearing techniques do exactly that and make it feasible to image large whole-
samples with fluorescence or light microscopy, without mechanical sectioning. 
5.1. Advantages 
+ Retaining of the structural information of a sample 
Biological samples are inherently three-dimensional (3D). In most classical 
methods, aimed at the analysis of both structural and molecular information, 
samples are divided into smaller sections. These sections of the, initially, 3D 
sample often resemble a two-dimensional (2D) structure. A common process 
employed to transform a sample into a 2D structure is mechanical sectioning with 
cryostats or microtomes. This process destroys the structural relationship between 
the different components within a sample, such as cells or neurites, and therefore 
prevents the tracking of features between serial sections, such as fibre tracing. It 
is possible to reconstruct the 3D structure of a sample from sections but this 
process is usually laborious, and may introduce structural innacuracies due to 
tissue deformation introduced during the mechanical cutting process or during 
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histological processing. Furthermore, mechanical sectioning can be generally time 
consuming if one aims to manually image every section of a sample. 
Automated high-throughput methods for mechanical sectioning have tackled 
some of its drawbacks, such as its laboriousness, expensiveness and the user-
introduced damage to the tissue. These include serial block-face mechanical 
methods (A. Li, 2010), and can be combined with both two-photon tomography 
(Ragan et al., 2012), electron microscopy (Winfried Denk & Horstmann, 2004) or 
array tomography (Micheva & Smith, 2007). The major limitations of these 
techniques include the non-compatibility with molecular labelling, the speed of 
acquisition, the difficulty of set up and, ultimately, the destruction of the sample. 
Economo and colleagues tackled the lack of molecular labelling and, in part, the 
speed of acquisition with the development of a high-speed volumetric serial two-
photon (STP) tomography (Economo et al., 2016). While this technology is capable 
of imaging over 50 mm3/day and 16 megavoxels/s, representing a 16-48x increase 
over conventional laser-scanning microscopes, it still takes approximately one 
week of imaging time for a whole mouse brain. As a comparison, a light sheet Z.1 
microscope (ZEISS) can acquire 127 megavoxels/s3. Therefore, limitations remain 
for high-speed volumetric STP tomography in terms of speed of acquisition for 
large samples and lack of commercial availability. 
Tissue clearing methods have the advantage of allowing for the imaging of intact 
biological samples without the need for mechanical sectioning, thanks to rendering 
the sample transparent. The imaging of a whole transparent sample can be 
achieved with conventional microscopy methods, which are widely available, such 
as light sheet, confocal or two-photon microscopy. In this manner, the structural 
information of a sample is retained.  
+ Compatibility with molecular phenotyping 
Molecular phenotyping of a biological sample is achieved either by the expression 
of a genetic reporter coupled to the molecular component of interest, such as a 
fluorescent protein, or by the detection of a molecular component with reporter-
tagged affinity molecules, such as whole-tissue immunostaining with antibodies. 
Different tissue clearing methods are compatible with one or both of these 
approaches of molecular phenotyping, thus providing a substantial advantage for 
the molecular interrogation of research samples, as opposed to whole-structure 
imaging methods such as MRI. In addition, fluorescent molecular phenotyping 
allows for the multiplexed interrogation of molecular components in the same 
sample, by the application of fluorescent reporters with differing excitation and 
emission spectra. Specifically, the CLARITY method allows for the molecular 
                                                   
3 Own calculations assuming a frame of 1920x1920 pixels and a minimum camera exposure 
time of 29 ms. 
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phenotyping of not only proteins but also microRNAs and mRNAs through 
multiplexed in situ hybridization (Sylwestrak, Rajasethupathy, Wright, Jaffe, & 
Deisseroth, 2016). 
+ Multiple rounds of molecular phenotyping in the same sample 
Even with the use of optically separable fluorescent reporters for multiplexing of 
molecular phenotyping, one is still limited by the often broad excitation and 
emission spectra. Such phenomena place the cap for multiplexing in cleared 
samples at around 3-5 fluorescent reporters per sample, depending on the 
imaging system. Conveniently, some tissue clearing methods allow for the 
detergent-mediated removal of affinity-based reporters which were applied during 
a previous round of molecular phenotyping (Chung et al., 2013; Murray et al., 2015). 
This process facilitates the re-interrogation of the same sample with another set of 
affinity based-reporters and, in this manner, dispenses the need for more biological 
replicates and prevents the difficulties associated with biological variability 
between samples. 
+ Speed of acquisition 
When tissue clearing and imaging by light sheet microscopy are combined, an 
unprecedented speed of acquisition is achieved. The merge between these 
technologies make it feasible to image large biological samples in high-resolution 
and in enough replicates to answer a biological question. For example, Tomer and 
colleagues achieved the imaging of a Thy1-eYFP whole mouse brain at 10x 
magnification in ~4 h (Tomer, Ye, Hsueh, & Deisseroth, 2014). 
+ Easy digital reconstruction and 3D visualization 
The numerical aperture (NA) of a microscope objective refers to its ability to 
capture light and resolve details of a sample. Typically, NA increases with an 
objective’s magnification, which in turn is inversely correlated with the field of view. 
Upon imaging, if a sample does not fit in the field of view and one does not wish 
to decrease the resolution, images need to be separately acquired at multiple 
positions and encompassing the whole volume of interest in a process named 
tiling. Post acquisition, these tiles need to be reconstructed into a single 3D 
volume, in a process named stitching. In other words, while in mechanical 
sectioning methods the sample is physically cut, in tissue clearing imaging the 
sample is instead optically cut, with accurate preservation of the positional 
coordinates of each tile in order to ensure faithfull reconstruction of its 3D 
structure. A digitally reconstructed 3D sample allows for the visualisation of its 
original morphology and provides an accurate representation of the location of its 
components relative to one another. Substantial advances in bioinformatic tools 
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for tile stitching have progressively made this reconstruction process straight 
forward and time. Some examples of these tools are Terasticher, Arivis, Imaris 
Stitcher and Big Stitcher (Bria & Iannello, 2012). 
+ Fibre tracing 
The understanding of the brain can greatly benefit from the study of the 
interconnections between structure and function at a whole organ level, as 
exemplified by the brain’s long ranging connections. The connectome is defined 
by Defelipe as the map of brain connections at the macroscopic and intermediate 
levels, while the synaptome is regarded as the same study at an ultrastructural 
level (DeFelipe, 2010). Methods for the study of the connectome and synaptome 
traditionally require large amounts of time for imaging and data processing 
(Kasthuri & Lichtman, 2007). The tissue clearing method CLARITY has been shown 
to achieve high-speed imaging while allowing for brain-wide projection mapping, 
by direct observation of cell fibres (Ye et al., 2016) or, indirectly, by observation of 
their input/output cell bodies (Menegas et al., 2015). Individual fibre tracing has also 
been demonstrated in other tissue clearing methods, as in 3DISCO (Belle et al., 
2014), and synaptic-scale resolution can be achieved in some cases, as in SeeDB2 
(M. Ke et al., 2016). 
In studies addressing the function of a specific brain region, or in cases where fibre 
density is too high to trace an individual neurite, it can be of use to fluorescently 
mark the neurites belonging to a subpopulation of neurons. Lipophilic neuronal 
tracers, such as DiI, can achieve this and have the advantage of binding to cellular 
membranes, which prevent them from diffusing before sample fixation. However, 
many tissue clearing methods work precisely by removing lipids to reduce light 
scattering and, thereby, turn the sample transparent. Therefore, during the clearing 
process the lipophilic tracers are also washed away. However, the lipophilic dye 
DiD can be used by direct dissolution in the clearing reagent, as shown by the 
labelling of myelinated fibres in the SWITCH protocol (Murray et al., 2015). Yet, this 
approach labels all myelinated populations of neurons within the samples, rather 
than specific populations of interest. Certain aqueous-based detergent free 
clearing protocols, such as ScaleS, seeDB, ClearT and FRUIT, are able to preserve 
lipids, and, in consequence, the lipophilic neuronal tracers (Hama et al., 2015). Yet, 
seeDB, clearT and FRUIT are limited in the depth of imaging they facilitate.  
Furthermore, ScaleS’ clearing capability is slightly lower than alternative lipid 
clearing methods, such as CLARITY and CUBIC. Jensen and Berg have addressed 
this limitation by testing DiI-analogue dyes with molecular modifications that make 
them aldehyde-fixable and, thus, less clearable during the CLARITY protocol 
(Kristian H R Jensen & Berg, 2016). Indeed, these DiI-analogue dyes are compatible 
with CLARITY, with CM-DiI displaying the sharpest and FM1-43FX the strongest 
fluorescent signal. These methodological advances open new avenues to 
neuronal tracing in conjunction with tissue clearing.  
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In paper III, we aimed to apply the fibre tracing capacities of tissue clearing to the 
study of dopaminergic fibres in the newt brain, both in development and in 
regeneration. Although we used a different approach to fibre tracing, neuronal 
tracing dyes have previously been used in the newt, Pleurodeles waltl newts to 
inform on afferent and efferent connections to the striatum, as well as 
catecholaminergic innervation of the striatum and nucleus accumbens (Oscar 
Marín, González, & Smeets, 1997a, 1997b; Oscar Marín, Smeets, & González, 1997). 
The joining of tissue clearing with neuronal tracing dyes could further enlighten the 
suggestive regeneration phenomenon in the midbrain-to-striatum pathway of 
newts. 
+ Extraction of 3D measurements 
The study of samples in 3D allows for the measurement of unique properties of 
brain-wide projecting fibres, that would not be possible in 2D representations 
without accurate reconstruction. Some examples of these parameters are the 
measurement of the projection angle of a fibre, the number of dendrite terminal 
points, the length of all the fibres belonging to a specific cell body and the number 
of branching points (paper III). If aiming to find out the density of arborisation in a 
3D region, one can also perform Sholl analysis, which measures the number of 
intersecting fibres in a number of concentric circles (Langhammer et al., 2010; Sholl, 
1956). Such measurements can inform on differences between cell types, through 
characterization, and cell function, through correlation with in vivo or ex vivo 
studies. 
5.2. Limitations 
- Alterations in tissue morphology 
Many tissue clearing methods induce the expansion or shrinking of a sample, 
throughout the clearing protocol (Kolesová, Čapek, Radochová, Janáček, & 
Sedmera, 2016). In some, the alteration in morphology is transient while in others 
it is permanent. These changes in tissue size can potentially result in non-
homogeneous deformations of tissue morphology. While clearing techniques such 
as SeeDB and Scale U2 are able to clear tissue without morphology alterations, 
the extent of clearing in large samples and the length of the protocol are certainly 
issues (Richardson & Lichtman, 2015). To address the alteration of morphology 
limitation in tissue clearing techniques, cellular and subcellular structures can be 
compared by hematoxylin and eosin staining in cleared and uncleared samples 
(Gómez-Gaviro et al., 2017). For nanoscale structure one can only monitor changes 
with transmission electron microscopy (Gómez-Gaviro et al., 2017). It has been 
shown that different clearing methods have a different degree of preservation of 
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the subcellular structure (Hama et al., 2015). This should be taken into account 
upon the choice of a method, if the preservation of the subcellular structure is 
important. Morphological alteration may also be less of a problem if quantifications 
are compared within the same clearing protocol, rather than between different 
ones. 
- Protein loss 
Tissue clearing techniques can result in protein loss throughout the clearing 
process (Fig. 6). If the sample being cleared has a weak expression of a reporter 
or if the protein to be detected is present already in very low quantities, then 
molecular phenotyping may be limited after clearing. In the cases where protein 
loss represents a problem this can be minimized by a process called hydrogel-
tissue hybridization, where hydrogel monomers enter the tissue and are 
subsequently polymerized into a hydrogel mesh which covalently cross-links 
proteins in the tissue (Fig. 7; Chung et al., 2013). 
 
Figure 6 | Amount of protein loss by the end 
of in four tissue clearing processes: CLARITY, 
4% SDS, ScaleU, Triton X (0.1%). Reproduced 
with permission from Chung et al. (2013). 
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Figure 7 | Hydrogel-tissue infusion, hybridization and tissue 
clearing process in the CLARITY protocol. First, the tissue is 
infused with hydrogel monomers and cross-linked with 
formaldehyde. Second, the hydrogel monomers are induced to 
polymerize into a mesh by a temperature increase. This is 
followed by SDS-based lipid clearing. A major proportion of the 
protein content is kept due to the hydrogel mesh which is in 
place during the clearing process. Reproduced with permission 
from Chung et al. (2013). 
- Duration of the protocol 
From start to end, tissue clearing protocols can take days, weeks or even months, 
depending on the technique and thickness of the sample (Richardson & Lichtman, 
2015). While this is a limitation, depending on the technique, actual hands-on time 
can be very limited and comparable to traditional sectioning and immunostaining. 
Furthermore, we rely more and more on the development and commercialization 
of technological solutions capable of performing most of the protocol steps 
automatically and with high reproducibility (e.g. solutions from LifeCanvas 
Technologies and the X-CLARITY system from Logo Biosystems). 
In paper III, we optimized the Advanced CUBIC method, not only in terms of 
minimizing sample fragility but also in terms of reducing the protocol time from 16 
to 9 days. 
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- High start-up costs 
Some tissue clearing techniques represent high costs in terms of reagents and RI 
matching solutions, such as FocusClear currently selling at 36$/ml. Furthermore, 
specialized equipment may also be required, for example the need for an 
electrophoretic tissue clearing chamber in the initial CLARITY publication (Chung 
et al., 2013). In this case, the development of passive clarity has dispensed the 
need for the chamber but, in exchange, increased protocol duration (Tomer et al., 
2014). Tissue clearing techniques with cheaper reagents and lower equipment 
requirements exist, such as CUBIC (E. a. Susaki et al., 2014). However, the choice 
of technique depends on many factors, such as the size of the sample, the need to 
remain free of toxic reagents, the retaining of functional fluorescent proteins and 
the compatibility with immunostaining (Richardson & Lichtman, 2015). If the 
purchase of a light sheet microscopy is required, this is another substantial cost to 
consider. The establishment of collaborations with facilities which can provide 
access to this technology is a way to circumvent such investment. Light sheet 
microscopy is becoming more widespread across academic institutions and, 
perhaps in the future, we will see a light sheet microscope in every 
laboratory/department just as with confocal microscopy. 
- Big data 
The imaging of large samples in high-resolution results in large amounts of data 
being created, often in the terabyte range. Data processing, such as stitching, 
creates further copies of the original datasets, adding to the data storage 
requirements. Handling such big datasets requires also large amounts of 
computational memory so that the computational algorithms can run effectively. 
Besides the need for high computing power and large storage space, high network 
transfer speeds are also required to move the data or share it. Despite the 
existence of cloud storage services like Amazon S3, pushing terabytes of data 
routinely over the network is not practical. The solution is to keep the data locally 
and to invest in high-speed local networks, computer power and storage space. 
Such solutions are more easily implemented at the level of core facilities rather 
than individual laboratories. Apart from data volume, there is no file format or 
framework standard for sharing light sheet microscopy data or comparing it with 
data from other systems. Partly addressing this gap, Fürth and colleagues 
proposed an interactive framework for sharing connectivity and mapping data 
across laboratories and imaging technologies, including wide field, confocal and 
light sheet microscopy (Fürth et al., 2017). 
 27 
5.3. A historical perspective 
Both the use and development of tissue clearing techniques have proliferated in 
the last decade, but its first description is attributed to Spalteholz a century ago 
(Spalteholz, 1911, 1914; Vigouroux, Belle, & Chédotal, 2017). Spalteholz treated 
tissues with a mixture of benzyl alcohol and methyl salicylate, thus rendering them 
transparent by replacing its water with organic compounds having higher RI. At the 
time, there were no microscopes capable of imaging deep enough into cleared 
tissue to take advantage of is transparency. 
It was not until 1990 that the first two-photon laser scanning fluorescent 
microscope was made available (W Denk, Strickler, & Webb, 1990), soon followed 
by the first light sheet microscope (Voie, Burns, & Spelman, 1993). Since then and 
throughout its development, these technologies increasingly pushed the depth 
boundary of tissue imaging. One more decade passed before the introduction of 
the first commercially available clearing solution – FocusClear (Y. C. Liu & Chiang, 
2003). While this allowed for high resolution deep imaging by making use of a 
confocal microscope, its contents remained proprietary and highly expensive for 
use with large samples/experiments (Y. C. Liu & Chiang, 2003). Helmchen further 
demonstrated the potential of deep tissue imaging by successfully using a two-
photon microscope to acquire images 800 µm deep into the mouse neocortex 
(Helmchen & Denk, 2005). Following this depth breakthrough, a whole mouse 
brain was successfully imaged with a modified ultramicroscope, by making use of 
a clearing solution made of a mixture of benzyl-alcohol and benzyl-benzoate 
(BABB) (Dodt et al., 2007). Although BABB does render tissue highly transparent, 
it has toxic properties and molecular phenotyping is hindered by the fast 
quenching of fluorescent protein emission (~half a day) (Dodt et al., 2007; 
Richardson & Lichtman, 2015). This quenching issue has later been addressed in a 
modification of the BABB protocol, entitled FluoClearBABB (Schwarz, Scherbarth, 
Sprengel, & Engelhardt, 2015). 
 It was, however, in 2011 that three essential factors for the success of tissue 
clearing methods come together: (i) a new clearing agent with an open source 
formula and capable of preserving fluorescent signals in labelled samples – Scale 
(Hama et al., 2011); (ii) the launch of the first commercial light sheet microscope by 
LAVision, providing rapid sample imaging in high resolution; (iii) developments 
within computer processing power, network infrastructure and data storage, 
making practical analysis of light sheet data feasible. Thanks to this combined 
effort the tissue-clearing field is currently branching out towards numerous 
applications, uncovering brain features previously deemed inaccessible by depth, 
reconstruction or resolution limitations. Furthermore, constant bioinformatic 
developments are making the data stitching and neuronal tracing faster, more 
accurate and more user-friendly (Bria & Iannello, 2012; Hörl, Rusak, Harz, Treier, & 
Preibisch, 2017; Usher et al., 2017). 
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5.4.The different methods 
Since the introduction of Scale we have seen the development of a vast number 
of clearing techniques, tackling issues such as fluorescent protein quenching, 
speed of clearing, sample deformation and toxicity (Feuchtinger, Walch, & Dobosz, 
2016; Richardson & Lichtman, 2015, 2017), or focusing on protocol optimizations 
for specific applications (Kubota et al., 2017). The best taxonomy to categorize 
modern clearing methods is still debatable. Richardson and Lichtman proposed 
clustering the techniques based on the physical mechanism underlying the 
clearing process: (i) Solvent-based; (ii) Simple immersion; (iii) Hyperhydration; (iv) 
Hydrogel embedding; (v) Hydrogel embedding and hyperhydration (Richardson & 
Lichtman, 2015, 2017). Clusters ii-v belong, at a higher-level category than 
aqueous-based clearing. Instead, Silvestri and colleagues proposed clustering 
clearing techniques based on their intended application: (i) whole organ light sheet 
microscopy-based imaging; (ii) large area confocal or two-photon microscopy-
based imaging (Silvestri, Costantini, Sacconi, & Pavone, 2016). Each of these two 
categories is then split into endogenous fluorescence or ex-vivo staining. While 
both taxonomies have logic, the constant specialization and application-based 
variations of clearing protocols might create too much of an overlap between 
techniques, thereby making it difficult to attribute them to a specific classification. 
In this section, we will use the taxonomy based on the physical mechanism of 
clearing to discuss the differences between methods. 
Most tissue clearing methods have 2-4 protocol steps in common (Richardson & 
Lichtman, 2017; Tainaka, Kuno, Kubota, Murakami, & Ueda, 2016): (i) pre-treatment; 
(ii) permeabilization and delipidation; (iii) Immunolabelling; iv) RI matching. First, 
during the pre-treatment step, samples are treated with decolourization/bleaching 
reagents to remove light-absorbing or auto fluorescent pigments. During this step, 
certain techniques opt instead to embed the sample in a hydrogel to prevent 
protein loss or keep the components together during sample expansion. Secondly, 
during the permeabilization and delipidation step, the sample is exposed to 
detergents or organic solvents in order to remove lipids and facilitate the 
penetration of reagents in later steps. Thirdly, during the immunolabelling step, the 
sample is exposed to affinity molecules that will bind to the targets to be detected. 
These molecules can penetrate the sample passively, through simple diffusion, or 
actively, through the exertion of pressure or electric current. If immunolabelling is 
not required or if the sample already contains natively expressed fluorescent 
proteins, then this step can be omitted. Lastly, during the RI matching step, the RI 
of the sample is equilibrated by impregnation with a variety of solutions which 
homogenize the RI.  
 29 
* Solvent-based clearing methods 
These methods work by a dehydration and lipid solvation step, followed by a RI 
adjustment step with an organic solvent with a RI close to the dehydrated tissue 
(Richardson & Lichtman, 2015). 
Since solvent-based methods, such as 3DISCO, remove water from the sample and 
water is needed to maintain emission of most fluorescent proteins, these end up 
quenched, thereby preventing the analysis of these endogenous reporters (Ertürk, 
Lafkas, & Chalouni, 2014). Later developments of these techniques (uDISCO) have 
minimized this issue by the substitution of dibenzyl ether (DBE) with diphenyl ether 
(DPE) (C. Pan et al., 2016). In this case, fluorescent emission is preserved for at least 
a few weeks at imageable levels, although still decreasing with time. However, this 
progressive drop in fluorescence limits the comparison of expression levels based 
on fluorescent signal intensity, unless the samples are compared at the exact same 
time points post clearing, which is a rather challenging. Furthermore, the solvents 
used in these methods are corrosive and can potentially damage imaging 
objectives in some microscopes. This can, however, be circumvented by isolating 
cleared samples in tubing with a RI which matches the imaging media and 
objective. Lastly, solvent-based methods typically induce sample shrinking, which 
can be an advantage in terms of the amount of data acquired or a disadvantage, if 
the features to be observed are at the limit of the microscopes resolution. 
In paper III, we chose not to use solvent-base methods due to the corrosive 
characteristics of the solvents involved and their incompatibility with the objectives 
used in the light sheet Z.1 microscope. Another reason for our choice, is the 
fluorescence quenching which is observed over time with these methods. 
Solvent-based clearing methods include Spalteholz method, BABB/Murray’s clear, 
3DISCO, iDISCO, iDISCO+ and uDISCO (Dodt et al., 2007; Ertürk et al., 2012; C. Pan 
et al., 2016; Renier et al., 2014, 2016, Richardson & Lichtman, 2015, 2017). 
* Simple immersion 
These methods work by replacing the liquid inside the tissue with a high RI 
solution, in order to average the RI of the sample and thereby achieve a similar 
sample RI to the liquid it is immersed in (Richardson & Lichtman, 2015). Most of 
these techniques are easy to implement and preserve lipids, which can be an 
advantage if using lipophilic neuronal tracing dyes, as they will be not be removed 
during clearing. It can however be a disadvantage, as clearing effectiveness can 
be lower, as well as antibody penetration during immunostaining. 
Simple immersion clearing methods include sucrose, FocusClear, ClearT, ClearT2, 
SeeDB, SeeDB2G, SeeDB2S, FRUIT, TDE,  CUBIC-Cancer, FAST-Clear and Ce3D 
(M. Ke et al., 2016; Kubota et al., 2017; W. Li, Germain, & Gerner, 2017; A. K.L. Liu, 
Lai, Chang, & Gentleman, 2017; Richardson & Lichtman, 2015, 2017). 
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* Hyperhydration 
These methods work by removing lipids and thereby reducing the RI of the sample 
(Richardson & Lichtman, 2015). For lipid removal, they make use of detergents, 
which is a slow process and requires multiple solution changes. Hyperhydration 
methods can result in high protein losses (24-41%) and, in consequence, a weak 
immunostaining signal due to the reduced amount of epitopes (Chung et al., 2013; 
Richardson & Lichtman, 2015). These methods use urea to facilitate penetration of 
the clearing detergents, by partially denaturing proteins in hydrophobic regions of 
the tissue.  
The clearing protocol presented in paper III is an optimization of a hyperhydration 
method, CUBIC (E. a Susaki et al., 2015). The first reagent in this protocol uses urea 
for hyperhydration, quadrol for decolourization and Triton-X 100 for delipidation 
(Tainaka et al., 2016). The second reagent expedites the clearing process by using 
sucrose and again urea for hyperhydration and triethanolamine for delipidation 
(Richardson & Lichtman, 2015; Tainaka et al., 2016). 
Hyperhydration clearing methods include Scale A2, Scale U2, Scale S CUBIC and 
whole-body CUBIC (Hama et al., 2011, 2015; E. a. Susaki et al., 2014; E. A. Susaki & 
Ueda, 2016; E. a Susaki et al., 2015). 
* Hydrogel embedding 
These methods address the protein loss that occurs during hyperhydrating 
alternatives. They do so by embedding the tissue in a hydrogel mesh prior to 
clearing (Chung et al., 2013). Then, lipids are removed with detergent solutions and 
electrophoresis, followed by RI matching. By doing so, high transparency and 
antibody penetration can be achieved in large samples, with only about 8% protein 
loss (for CLARITY cleared samples). Some hydrogel based methods have 
additional advantages, such as improving antibody distribution by activating 
antibody binding post-antibody penetration (SWITCH), or enhancing antibody 
penetration by the use of pressure (ACT-PRESTO) or an electric field (stochastic 
electrotransport) (Kim et al., 2015; E. Lee et al., 2016; Murray et al., 2015). 
Hydrogel embedding methods include CLARITY, PACT, PARS, Bone CLARITY, 
ACT-PRESTO, SWITCH, SCM and stochastic electrotransport (Chung et al., 2013; 
Greenbaum et al., 2017; Kim et al., 2015; E. Lee et al., 2016; Murray et al., 2015; 
Sung et al., 2016; B. Yang et al., 2014). 
* Hydrogel embedding and hyperhydration 
These methods take advantage of the sample expansion observed in 
hyperhydration methods and the capacity of the hydrogel-based methods to keep 
the sample components together to perform controlled expansion of the sample 
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with minimal morphological distortion. This process gave rise to expansion 
microscopy, in which diffraction-limited microscopes can be used to image 
samples at biological scales only before deemed possible by super resolution 
microscopy. 
At the time of writing of this thesis two expansion tissue clearing protocols exist: (i) 
MAP, which allows sample expansion up to 4-5x the original size (Ku et al., 2016); 
(ii) iExM, which allows for sample expansion up to 20x the original volume by using 
more than one round of expansion (Chang et al., 2017). 
The direct and unbiased comparison of clearing methods is necessary for users to 
perform an informed choice of the best alternative to their application. Orlich and 
Kiefer have partially filled this gap by directly comparing ten clearing techniques in 
the mouse brain, muscle, heart, kidney and lung, and also in embryos and foetuses 
at different developmental stages (Orlich & Kiefer, 2017). The clearing methods 
compared in this study were: Murray’s clear, 3DISCO, Scale, SeeDB, FRUIT, CUBIC, 
CUBIC-perfusion, ClearT2, CLARITY, PACT, 
For CLARITY based protocols, Jensen and Berg provide a comprehensive review 
of the different alternatives and optimizations, as well as providing advice on which 
factors to consider when choosing a protocol, such as the type of tissue, the speed 
of clearing, the type of staining required, the price of the optical clearing solution 
and the imaging options available (Kristian H.Reveles Jensen & Berg, 2017). 
5.5. Applications 
Imaging deep into tissue and the visualization of large samples in 3D by tissue 
clearing methods have allowed for novel research studies and applications. Here 
we discuss some of these in respect to brain studies. 
* Cancer metastasis profiling at a whole-brain level 
Kubota and colleagues optimized the CUBIC tissue clearing protocol for the 
imaging of cancer metastasis at a whole body/organ level (Kubota et al., 2017). 
Given this method’s capacity for single-cell resolution, even micro metastasis can 
be detected. In this study, mice were intracardiacally injected with two metastatic 
cancer cell lines and the newly developed metastasis in their brains were classified 
in terms of their histological patterns. The results suggest that different cell lines 
spread differently through the blood vasculature. While some may promote 
angiogenesis of new vasculature to support their growth, others migrate to pre-
existing vasculature to take advantage of their nutritional maintenance potential. 
The same study demonstrates the use of tissue clearing to study the 
spatiotemporal dynamics of metastatic progression and the therapeutic effect of 
anti-tumour drugs, by screening for volume and number of foci. Other studies have 
merged tissue clearing, automatic segmentation and quantification methods and 
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the study of anti-tumour drugs. By doing so it is possible to inform on tumour 
morphology, vasculature and drug penetration, providing a more representative 
overview than with mechanical sectioning (Dobosz, Ntziachristos, Scheuer, & 
Strobel, 2014; Feuchtinger et al., 2016). 
These approaches could be of value when performing in vivo studies on the anti-
tumour effect of trifluoperazine, the anti-glioblastoma drug reported in paper I.  
* Integration of brain grafts in a hosts brain 
One study has examined the integration of neuroepithelial-like stem cells in mice 
brains by marking cells with lentiviral vectors, followed by transplantation of the 
grafts into the brain and infection with rabies virus (Doerr et al., 2017). Such 
procedure allows for rabies-mediated trans-synaptic tracing and shows that, not 
only can the grafted cells integrate with the hosts neurons, but they can also 
project in different amounts and to different areas depending on their input 
transplanted region. Another study has used the tissue clearing technique SeeDB 
to research the interaction of implanted glioblastoma cells and mesenchymal stem 
cells in the zebrafish brain (Vittori et al., 2016). 
* Wiring and molecular features of brain regions 
CLARITY tissue clearing has been used in the study of the projections and 
molecular phenotype of cell subpopulations in the prefrontal cortex of mice (Ye et 
al., 2016). This study shows that different cell populations in the prefrontal cortex 
represent positive or negative emotion judgments and that this affects their wiring 
pattern, behaviour and gene expression. 
The same clearing method, CLARITY, has been applied in the study of the 
substantia nigra pars compact (SNc) dopaminergic subcircuits, facilitating the 
identification of two different nigrostriatal dopaminergic circuits, based on their 
inputs, outputs, biophysical parameters and how their environmental information 
was represented (Lerner et al., 2015). 
* Spatiotemporal study of nerve regeneration 
The optic nerve is not part of the brain but we comment on this study in the context 
of nerve regeneration within the central nervous system (CNS) in paper III. 
Diekmann et al. used FocusClear to perform whole mount tissue clearing of retinal 
cell cultures of transgenic zebrafish (Diekmann, Kalbhen, & Fischer, 2015). They 
show the spatiotemporal regeneration of individual axons in the zefrafish retina, 
setting up a platform for the mechanistic understanding of CNS regeneration in 
zebrafish. 
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* Mapping of brain activity 
Renier and colleagues have combined the tissue clearing method iDISCO+ with 
automated bioinformatics pipelines for cell detection and registration in order to 
observe brain activity at cellular resolution (Renier et al., 2016). Brain activity is 
measured by expression of the immediate early gene, c-fos, whose expression 
reflects recent neuronal activity. The bioinformatics part of this method is entitled 
ClearMap. By applying iDISCO+ and ClearMap, this study was able to detect brain 
regions activated in response to haloperidol, a dopamine receptor (DR) antagonist 
and anti-psychotic drug. The same study could also link brain activity with specific 
behaviours, such as the exploration of new environments with or without whiskers 
in mice. 
* Forensic medicine investigations 
To investigate infant head injury post-mortem in suspected cases of abusive head 
trauma (Cheshire et al., 2015). This method allows for the detection of small 
amounts of bleeding in the dura mater. 
* Label-free brain imaging 
The tissue clearing method SWITCH was reported to extend the imaging depth of 
optical frequency domain imaging, a technology based on detecting photons 
scattered from tissues, from 1-2 mm to the whole mouse brain depth (Ren, Choi, 
Chung, & Bouma, 2017). This methodological combination is entitled Clearing 
Assisted Scattering Tomography (CAST) and makes it possible to perform 
connectome and volumetric studies completely label-free. 
* Neuroanatomical studies 
One study has applied BABB tissue clearing to samples of mice cerebellum in 
order to study the spatial distribution of Purkinje cells in 3D (Silvestri et al., 2015). 
They developed automated algorithms for cell identification, which then facilitated 
the identification of gaps in the lamellar organization of Purkinje cells, which are 
suggested to play a role in autism disorders. This study also opens new 
possibilities for new ways of anatomical division, based on the clustering analysis 
of Purkinje cells. 
Another study has used CLARITY and light sheet microscopy to answer if midbrain 
dopaminergic neurons projecting to different brain regions would form distinct 
subclasses based on their projection inputs (Menegas et al., 2015). By applying 
rabies retrograde trans-synaptic tracing systems, this study demonstrates that 
midbrain dopaminergic neurons with projections to the posterior striatum receive 
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major inputs from the zona incerta, the globus pallidus and the subthalamic 
nucleus.  
* Neurodegeneration studies 
Liebmann and colleagues have used iDISCO and the ClearMap bioinformatic 
software to detect amyloid plaques in the brains of mice and in human archival 
samples (Liebmann et al., 2016). They demonstrate this to be a rapid and accurate 
method to quantify amyloid plaques in terms of number, density, volume, relative 
distance and sphericity. 
Other studies have also shown tissue clearing to be able to inform on 
neurodegeneration, such as in the imaging of Lewy bodies associated with PD and 
of mitochondrial proteins associated with respiratory chain deficiency in 
mitochondrial disease (Alan King Lun Liu et al., 2015; Phillips et al., 2016). 
* Development of brain organoids 
Renner et al. demonstrated the use of SWITCH tissue clearing in the study of the 
development and differentiation of human cerebral organoids (Renner et al., 2017). 
They show the existence of distinct ventral and dorsal regions in these organoids, 
many of which being linked. They further identify a forebrain organizing centre 
which secrete growth factors and provide spatiotemporal insights into the 
generation of different types of brain cells, such as neurons, astrocytes and 
oligodendrocytes. 
* Ischemic brain studies 
To quantify micro-vessels in a model of brain ischemic injury, one study applied 
3DISCO tissue clearing in combination with a hydrogel-fluorescent dye solution 
that marks micro-vessels (Lugo-Hernandez et al., 2017). This method allows for the 
quantification of vessel length and vessel density, as well as the distinction 
between vessels with different diameter, which differ in areas affected by focal 
cerebral ischemia. 
* Paper III – study of dopaminergic neurites and cell projections 
In paper III we have evaluated the performance of Advanced CUBIC and Advanced 
CLARITY in the study of dopaminergic neurites and ependymoglia radial 
projections (E. a Susaki et al., 2015; Tomer et al., 2014). The choice of these 
particular methods was based on the following factors: 
§ Reducing requirements for specialized equipment. 
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§ Compatibility with immunostaining. 
§ Easy-to-apply protocol. 
§ Prevention of protein loss (only in Advanced CLARITY). 
§ Specifically compatible with the light sheet microscope ZEISS Z.1. 
à In this microscope the sample is placed within a chamber which is 
open at the top and forced ventilation is not available. For this reason, 
toxic RI matching solutions, as the ones often used in solvent-based 
clearing methods, should be avoided. 
à The objective of this microscope does not support RI’s over 1.48, 
thereby limiting the choice of tissue clearing methods. For example, 
the solvent-based clearing method 3DISCO uses DBE (RI=1.56) as 
final clearing solution and is therefore incompatible with this objective 
(Ertürk et al., 2012). 

 37 
6. Cancer biology 
In order to develop new therapies that can halt or reduce cancer growth we need 
to understand how cancer cells within a tumour differ from each other. There are 
two main models to explain cancer cell heterogeneity: the classical clonal evolution 
model and the more recent cancer stem cell model (Shackleton, Quintana, Fearon, 
& Morrison, 2009). The first, the classical clonal evolution model, postulates that 
the different cell types within a tumour arise from genetic and epigenetic changes 
occurring in each individual cancer cell. The second, more recent model, argues 
for the existence of cancer stem cells, a discrete subpopulation of cells with 
tumorigenic potential, which exhibit self-renewal and differentiation capacities and 
are able to give rise to all the cancer cell types that are found within a tumour. 
Evidence for the cancer stem cell hypothesis come from several sources. For 
instance, discrete cell subpopulations in human cancers have been found to be 
the source of new cancer cells when transferred into immunocompromised mice. 
This has been shown in several cancers models, (Shackleton et al., 2009) 
including: breast (M. Al-Hajj, Wicha, Benito-Hernandez, Morrison, & Clarke, 2003), 
germ cell (Illmensee & Mintz, 1976; Kleinsmith & Pierce, 1964), leukaemia (Bonnet 
& Dick, 1997; Lapidot et al., 1994), brain (Singh et al., 2004) and colon (P. Dalerba 
et al., 2007; O’Brien, Pollett, Gallinger, & Dick, 2007; Ricci-Vitiani et al., 2007). 
Furthermore, these putative cancer stem cells all expressed particular marker 
combinations, such as CD44+/CD24- in breast cancer (M. Al-Hajj et al., 2003). The 
existence of cancer stem cells, with the ability to extensively proliferate, and other 
tumour cells, with limited ability for proliferation, implies a heterogeneous and 
hierarchical organization of cell types during cancer development (M. Al-Hajj et al., 
2003). Hierarchical organization in cancer refers to the existence of a usually 
unidirectional process of epigenetic changes from a tumorigenic to a non-
tumorigenic cancer cell phenotype (Shackleton et al., 2009). In this paradigm, non-
tumorigenic cells compose the bulk of the tumour. This hierarchical organisation 
has major implications for cancer biology since drugs targeting the cells which fuel 
cancer growth - i.e. the cancer stem cells - could prove more effective than 
targeting the already differentiated non-dividing cells. 
However, the cancer stem cell hypothesis cannot account for why lymphoblastic 
leukaemia with high-grade B cells do not naturally exhibit a hierarchical 
organization (Williams, Den Besten, & Sherr, 2007). However, a hierarchy can be 
artificially induced upon imatinib therapeutic treatment. Interestingly, the cancer 
stem cell model does not completely exclude the clonal evolution model. Indeed, 
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cancer stem cells could evolve through clonal evolution while simultaneously 
giving rise to their progeny, less stem-like, cancer cells (Shackleton et al., 2009).  
In this chapter we further explore the concepts of the cancer stem cell theory and 
its links to the differentiation of normal stem cells in homeostatic conditions. We 
also discuss the resistance of newts to cancer formation and the role of 
neurotransmitters in cancer. These two paradigms influenced our hypothesis that 
the neurotransmitter dopamine has a key role in glioblastoma (paper I). 
6.1. A stem cell disease 
Just as a normal tissue is heterogeneous and can contain self-renewing stem cells, 
progenitor and differentiated cells, tumour tissues are also believed to be 
heterogeneous by containing different cell types as well as homogeneous within 
each specific cell population. The cancer stem cell hypothesis explains tumour 
heterogeneity by the existence of cancer stem cells with tumorigenic potential, 
which can give rise to diverse types of non-tumorigenic cells within a tumour. 
Therefore, a cancer stem cell is defined as, a cell belonging to a tumour which has 
the capacity for self-renewal and for multipotentiality towards the different lineages 
of cancer cells that make up a tumour (Clarke et al., 2006). This model could partly 
explain both the resistance to anti-cancer drugs, as these could be targeting 
tumour cells that are not responsible for tumour growth, and also recurrence, as 
cancer stem cells can be left in the body after drug or surgical treatment and 
thereby serve as the genesis of new tumours (Shackleton et al., 2009). 
Cancer stem cells were first defined in 1997 by Bonnet and Dick in human acute 
myeloid leukaemia (AML) (Bonnet & Dick, 1997). They observed that a 
subpopulation of AML cells, with a marker profile of CD34++ CD38-, were the ones 
responsible for initiating human AML in mice. As mentioned at the beginning of the 
chapter, the identification of cancer stem cells has been replicated in many other 
cancers (Shackleton et al., 2009). 
The terms tumour-initiating cell and cancer stem cell are sometimes used 
interchangeably. This is because, to define a cell as a cancer stem cell, its 
properties, self-renewal and multipotentiality, need to be determined 
experimentally, just as with normal stem cells (Clarke et al., 2006). When this is not 
possible, the term tumour-initiating cell is more frequently used. The need for 
further clarification of these concepts has been identified in a review by Visvader 
(Visvader, 2011). Here, it is suggested that naming of “tumour-initiating cells” is a 
better term to denote the cell of origin in a given tumour, while “cancer stem cells” 
is a better term for the cells fuelling cancer propagation. 
Cancer stem cells were found to give rise to multilineage differentiated tumour 
cells with restricted proliferation potential, demonstrating a tumour hierarchical 
organization that, in turn, argues in support of the cancer stem cell hypothesis 
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(Piero Dalerba et al., 2011). Because of this hierarchical organization, the route for 
cancer stem cell differentiation from tumorigenic to non-tumorigenic cell, as well 
as the maintenance of cancer stem cells, is believed to be based on epigenetics. 
If cancer would evolve by stochastic genetic mutations then it would be hard for 
cancer stem cells to remain as a discrete cell population expressing particular 
markers. Several mechanisms behind the epigenetic regulation of cancer stem 
cells and cancer progression have been elucidated and are believed to act through 
pathways such as Wnt, Notch and sonic hedgehog (Shh) signalling (Toh, Lim, & 
Chow, 2017). 
While differentiated tumour cells are usually sensitive to conventional therapeutic 
agents such as radiation therapy and chemotherapy, it is believed that cancer stem 
cells display marked resistance to these therapeutic approaches (Muhammad Al-
Hajj, Becker, Wicha, Weissman, & Clarke, 2004). To tackle this, combination 
therapies could target both differentiated tumour cells and cancer stem cells, in 
this manner potentially preventing tumour relapses. Many clinical trials on 
epigenetic modulating drugs which are capable of targeting cancer stem cells 
therefore hold great promise towards the improvement of cancer therapies. 
Another possible avenue to the specific targeting of cancer stem cells is using 
immunotherapeutic approaches directed to the cancer stem cell phenotype (Q. 
Pan et al., 2015). Immunotherapy makes use of the immune system’s capacity to 
counteract diseases such as cancer. Break-through milestones in this field have 
already been achieved, such as the identification of the programmed death-ligand 
1 (PD-L1) immune checkpoint modulator which is expressed in some human cancers 
(Chen & Mellman, 2013). By blocking the interaction of PD-L1 with the PD-1 receptor, 
current therapies are able to restore the capacity for a patient’s T-cells to fight a 
tumour. This therapy has already shown a clinical benefit in lung cancer, melanoma 
and Hodgkin’s disease (Ansell et al., 2015; Q. Pan et al., 2015; Sharma, Wagner, 
Wolchok, & Allison, 2011; Topalian et al., 2012). PD-L1 expression in cancer stem 
cells is variable. While cancer stem cells in the head and neck carcinoma do 
express this immune checkpoint (Y. Lee & Sunwoo, 2014), malignant melanoma-
initiating cells show instead decreased expression levels (Schatton et al., 2010). 
Cancer stem cell antigens such as CD133, CD44, ALDH and HER2 are possible 
targets for further immunologically-based targeting (Q. Pan et al., 2015). Certain 
tumour microenvironment factors, such as IL-6, also have been shown to enhance 
cancer stem cells and could therefore also be potential targets for immunotherapy 
(L. Wang et al., 2009). 
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6.2. The link to regenerative biology 
As discussed in the previous section, cancer can be considered a stem cell 
disease. Furthermore, it exhibits parallels in stem cell regulation to normal tissue 
homeostasis, regenerative responses and tissue repair. One example of this is the 
regulation of the Wnt and Shh pathways. In cancer stem cells, these are believed 
to be epigenetically regulated to achieve maintenance and progression of the 
cancer stem cell identity (Beachy, Karhadkar, & Berman, 2004; Toh et al., 2017). 
Organ or appendage regeneration responses can resemble in part the embryonic 
signalling and pattern formation for a given tissue. In salamanders, Shh is 
expressed in both bud formation during limb development as well as in blastemas 
of regenerating limbs (Imokawa & Yoshizato, 1997). In accordance, inhibiting Shh 
signalling results in limb regeneration with loss of digits (Roy & Gardiner, 2002). A 
similar process is observed also in salamander lens, with Shh being expressed in 
both the developing and regenerating lens and inhibition of this pathway resulting 
in proliferation and differentiation defects (Tsonis et al., 2004). In single tissue 
regeneration responses, the Shh or Wnt pathways are also activated, as during the 
regeneration of prostate epithelium (Karhadkar et al., 2004) and during muscle 
regeneration (Polesskaya, Seale, & Rudnicki, 2003), respectively. Additionally, Wnt 
and Shh pathways are involved in the regulation of some cancers (Scales & de 
Sauvage, 2009; Zhan, Rindtorff, & Boutros, 2017). In fact, cancer could be seen as 
the prevention of return to normal conditions of the Wnt and Shh pathway 
activation. Adding to this line of thinking, Bmi-1, a gene dependent on the Shh 
pathway activity, is required in both hematopoietic stem cell renewal and in 
leukaemia propagation (Lessard & Sauvageau, 2003; Park et al., 2003). Taken 
together, the conservation of Shh and Wnt in cancer and regenerative responses 
suggests these processes to use similar signalling pathways and similar 
mechanisms for stem cell activation. However, it is important to note that only a 
limited number of pathways have been identified in the discussed scenarios and 
that Wnt and Shh are involved in many processes in, possibly, all multicellular 
organisms (N. Barker, 2008; Choudhry et al., 2014). 
When it comes to tissue repair and cancer, there are also suggestive links between 
these two phenomena. Conditions involving chronic tissue damage and repair, 
such as toxin exposure, chronic infection and inflammatory conditions, are also 
associated with a higher cancer risk (Coussens & Werb, 2002; Dvorak, 1986). The 
parallels between normal homeostatic conditions, cancer and tissue repair, 
suggest that cancer could be perceived as a permanent state of 
repair/regeneration (Fig. 8). With this model in mind, in acute injuries, stem cells are 
activated, give rise to differentiated progeny and then return to its quiescent state.  
However, in chronic injuries, stem cells are activated multiple times and in 
increasing numbers in response to constant injury. This increases the likelihood for 
an oncogenic event to occur at the stem cell level that will induce the genesis of 
oncogenic cells, or in other words transformation of a stem cell to a cancer stem 
cell. If following this theory, tissue which experiences higher levels of renewal 
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should also exhibit higher numbers of cancers. Indeed this is the case for the skin 
and lungs (Beachy et al., 2004). Hence, while regeneration is often seen as self-
renewal under control, cancer might be self-renewal outside of control. 
 
Figure 8 | The hypothesized roles of acute and chronic injury in stem cell activation. 
(Left) Acute injury leads to the loss of a portion of differentiated cells, which is then 
repaired through stem-cell activation. (Right) Chronic injury leads to the repeated 
expansion of the stem cell pool, preventing the number of activated cells from 
returning to normal values. This permanent expansion of the stem cell pool increases 
the probability of an oncogenic event to occur which forces the stem cell into a 
perpetual activated state. Reproduced with permission from Beachy et al. (2004). 
6.3.Resistance of newt tissues to cancer formation 
As highlighted earlier in Chapter 4, the newts display striking capacities for 
regeneration of a variety of organs and appendages. Surprisingly, these animals 
also have low frequencies of tumour formation upon exposure to carcinogenic 
compounds, which has been recorded in the regenerating lens (Okamoto, 1997) 
and limb tissues (Breedis, 1952; Tsonis & Eguchi, 1982). 
After lens removal, the dorsal iris epithelial cells re-enter the cell cycle and 
transdifferentiate to form a new lens, whereas, the ventral iris does not, highlighting 
cellular and molecular differences between these two tissues (Oviedo & Beane, 
2009). In an experimental context such as lentectomy, where the animals were 
exposed to carcinogenic substances, either the regeneration proceeded as 
normal, or the ventral iris, the tissue that is assumed not be the source of 
regenerative tissue, produced extra lenses with or without abnormalities 
(Okamoto, 1997; Oviedo & Beane, 2009). Because the exposure to carcinogens 
did not alter the structures formed by dorsal iris during regeneration, a causal 
relationship for the insensitivity of regenerative tissue to carcinogenic compounds 
and its resistance to cancer formation cannot be overruled.  
In one study, forelimbs of newts (Triturus viridescens) were injured by thermal or 
mechanic injury. Then, these animals were injected with either one of seven 
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different types of carcinogens or with neoplasm grafts from other amphibians. 
Surprisingly, non-neoplastic supernumerary limbs were induced in most cases, and 
sarcoma was only seen in 2 out of 500 animals (Breedis, 1952). In another 
experiment, forelimb blastemas of Japanese newts (Cynops pyrrhogaster) were 
treated with potent carcinogens, 20-methylcholanthrene and benzo(α)pyrene, 7 
days after limb amputation. Exposure to carcinogens resulted in altered or delayed 
regeneration patterns, but no tumour formation was observed (Tsonis & Eguchi, 
1982). In yet another investigation, the newts (Triturus cristatus)  were 
subcutaneously injected with carcinogens (benzpyrene, dibenzanthracene or a 
combination of both) at sites in the regenerative area of the tail or the non-
regenerative area of the trunk (Seilern-Aspang & Kratochwill, 1965). This study has 
recorded the appearance of tumours in regenerative tissues in 9% of injected 
animals, but this proportion was higher (15-16%) in non-regenerative tissues. 
Additionally, while 90% of the tumours in non-regenerative tissue were shifted to 
infiltrative and metastatic growth, the tumours in the regenerative tissue showed 
minimal infiltrative growth of 7%, and the remaining cases grew without invasion 
(Seilern-Aspang & Kratochwill, 1965). Altogether, these observations suggest an 
intriguing possibility of resistance to tumour formation in the regenerative tissue of 
the newts. Moreover, the mechanisms regulating cell dedifferentiation and 
differentiation appear to be distinct in newts, and this aspect is of particular interest 
in the context of tumorigenesis. As suggested by Oviedo and Beane, perhaps the 
regeneration-capable newt cells might not reach a fully dedifferentiated stem cell 
state, and therefore, carcinogenic compounds might act differently on them 
(Oviedo & Beane, 2009). Another possibility is that of the regulatory machinery in 
newt cells, which might repair carcinogen-induced damage better than other 
organisms. It is possible to test this hypothesis by single-cell sequencing of newt 
cells which are responsible for regeneration, before and after exposure to 
carcinogens and the availability of salamander genomes facilitates such studies 
(Elewa et al., 2017; Keinath et al., 2015; Nowoshilow et al., 2018). 
6.4. Neurotransmitters and cancer 
As the peripheral nervous system extends to all parts of the body, so can 
neurotransmitters reach all these body regions. Besides its classical function in 
neurotransmission through chemical synapses, many of these molecules have 
been linked to cancer initiation, regulation and maintenance, such as: 
acetylcholine, serotonin, dopamine, norepinephrine, epinephrine, glutamate and 
gamma-Aminobutyric acid (GABA) (Mancino, Ametller, Gascón, & Almendro, 2011).  
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* Acetylcholine 
Acetylcholine binds to two families of receptors: muscarinic (m-AchR) and nicotinic 
(n-AchR) (Mancino et al., 2011). Activation of the M-AchR type 2 with a specific 
agonist has been shown to inhibit glioblastoma cell proliferation as well as inducing 
apoptosis (Di Bari et al., 2015). In contrast, activation of M-AchR type 1 induced 
tumour invasion and metastasis in studies of prostate cancer (Magnon et al., 2013). 
In yet another study, m-AchR type 3 was found to have a growth-promoting effect 
in colon cancer cells (Ukegawa, Takeuchi, Kusayanagi, & Mitamura, 2003). Also, 
m-AchR activation was suggested to be implicated in the proliferation and 
propagation of breast cancer cells (Jiménez & Montiel, 2005). In the case of n-AchR 
receptors, nicotine and a derivate agonist which bind to n-AchR were found to 
stimulate proliferation of human small cell lung cancer cells (Schuller, 1989). Similar 
effects on n-AchR pathway activation have been found in mesothelioma, colon and 
gastric cancer cells (Mancino et al., 2011). 
* Serotonin 
Serotonin binds to seven families of receptors: 5-hydroxytryptamine1-7 (5-HT1-7) 
(Sarrouilhe, Clarhaut, Defamie, & Mesnil, 2015). It has been found to have a cancer 
stimulating effect, usually through the activation of 5-HT1 and 5-HT2 receptors. This 
cancer stimulating effect has been shown in the following cancers: prostate, 
bladder, small-cell lung, colorectal, bile ducts, womb, breast, hepatocellular and 
neuroendocrine (Sarrouilhe et al., 2015). The role of serotonin in cancer is believed 
to be concentration dependent, as low concentrations of this neurotransmitter lead 
to lower blood supply and therefore reduced tumour growth. In glioblastoma, lower 
levels of serotonin expression are related to longer survivals and it is believed to 
induce proliferation and angiogenesis (Caragher, Hall, Ahsan, & Ahmed, 2017). 
There are also indirect indications suggesting glioblastoma may synthesize and 
secrete its own serotonin molecules. 
* Norepinephrine and epinephrine 
Norepinephrine and epinephrine bind to two families of adrenergic receptors: α 
and β (Mancino et al., 2011). These neurotransmitters have been shown to regulate 
proliferation, survival and angiogenesis in ovarian cancer cells (Lutgendorf et al., 
2003; Thaker et al., 2006) as well as to induce metastasis formation in colon, lung 
and breast cancer cases (Ben-Eliyahu, Yirmiya, Liebeskind, Taylor, & Gale, 1991; 
Masur, Niggemann, Zanker, & Entschladen, 2001; Melamed et al., 2005). 
Furthermore, depletion of the β2 and β3 adrenergic receptors has been found to 
prevent early phases of prostate cancer development (Magnon et al., 2013).  
 
 
44 
* Glutamate 
Glutamate binds to two classes of receptors: metabotropic and ionotropic, which 
in its turn contain the AMPA, NMDA and kainite receptor families(Mancino et al., 
2011). The following cancers have been found to express glutamate or parts of its 
receptors: colorectal, glioma, gastric, prostate, oral squamous cell carcinoma, 
melanoma and osteosarcoma (Mancino et al., 2011). While higher levels of 
glutamate receptors are often associated with poorer prognosis in oral squamous 
cell and colorectal cancer, in colon cancer it is linked to lower drug resistance. 
Conversely, in medulloblastoma it correlates with higher tumour aggressiveness 
and recurrence.  
* Gamma-aminobutyric acid (GABA) 
GABA binds to two classes of receptors: ionotropic and metabotropic (Mancino et 
al., 2011). The following types of cancer have shown increased levels of this 
neurotransmitter: breast, ovarian, gastric and colon. Likewise, GABA receptors 
were found to be upregulated in breast and pancreatic cancer. 
 
The effects of the neurotransmitter dopamine in cancer are discussed in Chapter 
7. 
The link between cancer and regenerative biology, the resistance of newt tissues 
to cancer formation, the role of neurotransmitters in cancer and the capacity of the 
neurotransmitter dopamine to control neural stem cell fate in the newt brain, all led 
us to question of whether dopamine could exert a regulatory function in a brain 
cancer condition, glioblastoma. This reasoning gave rise to paper I.  
 
6.5. Glioblastoma 
* Classification 
A tumour of the brain with its origin in glial cells is generally termed glioma 
(“Definition of glioma,” 2018). Gliomas can be classified based on the type of glial 
cell in its origin (“Gliomas,” 2018): (i) ependymomas – arising from the tissue lining 
the ventricular system, the ependyma; (ii) astrocytomas – arising from astrocytes; 
(iii) oligodendrogliomas – arising from oligodendrocytes; and (iv) 
oligoastrocytomas – a mix between astrocytomas and oligodendrogliomas. A more 
clinical approach to glioma classification is the World Health Organization (WHO) 
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four-grade malignancy scale (I-IV) (Louis et al., 2016). Grade I glioma is the least 
malignant and is prevalent within children and young adults. Grade II-IV are used 
for infiltrating gliomas and its classification is based on histopathological 
characteristics of poor cellular differentiation, such as nuclear atypia, mitotic 
activity, proliferation of micro-vessels and necrosis. The most malignant glioma 
with the worse prognosis is grade IV, including for example glioblastoma. 
In a recent update of the WHO classification of tumours of the central nervous 
system, glioblastoma are classified into molecular subtypes, bases on their 
biomarker status for mutations in the isocitrate dehydrogenase (IDH) gene (Louis 
et al., 2016). The absence of IDH mutations, wildtype, has been associated with 
poorer prognosis, while its presence is associated with better prognosis (Combs 
et al., 2011). Genomic analyses have been able to identify further molecular 
subtypes of glioblastoma based on mutations or gene expression of EGFR, NF1, 
IDH1 and PDGFRA (Verhaak et al., 2010). This gave rise to a molecular subtype 
classification of glioblastoma: classical, mesenchymal and proneural. 
* Epidemiology and treatment 
Glioblastomas are the most prevalent malignant brain tumour group, with a survival 
median of only 12-14 months (Zhang et al., 2016). Standard treatment consists on 
surgical resection, radiotherapy and chemotherapy (Olson, Nayak, Ormond, Wen, 
& Kalkanis, 2014). Furthermore, the chemotherapeutic agent temozolomide has 
been found to increase survival by a few months. Whether or not a patient group 
benefits from this drug is correlated with the epigenetic status of the O6-
methylguanine–DNA methyltransferase (MGMT) promoter (Hegi et al., 2005; 
Jacinto & Esteller, 2007). Patients with a methylated MGMT promoter benefit from 
temozolomide while the ones without methylation do not. There is an unmet need 
for more effective drugs towards the treatment of glioblastoma. However, this is 
lacking not only due to a sparse amount of drug candidates but also due to the 
challenge of drug delivery across the brain barrier (Huse & Holland, 2010). While 
increasing drug dosing is a usual approach to achieve this crossing, this is largely 
limited by the drug’s toxicologically profile and associated maximum safely 
administered dose. 
* Cancer stem cells 
The marker CD133/Prominin 1 has been reported as specific to neural stem cells 
and cancer stem cells in brain tumours (Singh et al., 2003, 2004). Additionally, cell 
populations expressing this marker were linked to radio resistance (Bao et al., 
2006). However, more recent studies have created controversy over the specificity 
of this marker to tumour initiating cells. First, CD133- glioma cells were able to form 
tumours in mice (J. Wang et al., 2008). Second, CD133- tumour initiating cells were 
found in adult human gliomas (Ogden et al., 2008). Two hypotheses have been 
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provided to explain these controversial findings. One is that some gliomas might 
not follow a cancer stem cell model (Shackleton et al., 2009). Another is the primary 
cell culture and cell handling differences between studies, which could introduce 
biological variations (Huse & Holland, 2010). In the case of glioblastoma, the high 
heterogeneity between tumours may also represent a major hurdle to the finding 
of a specific cancer stem cell marker (Patel et al., 2014). 
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7. A discussion on dopamine 
Dopamine’s role as a neurotransmitter was discovered by Arvid Carlsson in 1957 
(Carlsson, 1993). We now know dopamine is a catecholamine, together with 
epinephrine and norepinephrine. Twenty catecholaminergic cell populations have 
been identified in the mouse brain (A1-A17 for dopamine and norepinephrine 
groups and C1-C3 for epinephrine groups) (Björklund & Dunnett, 2007). Of these, 
9 are dopaminergic populations (A9-A17; Fig. 9). The ventral midbrain contains 3 
dopaminergic populations: (i) retrorubral field (A8); (ii) SNc (A9); (iii) VTA (A10). 
 
Figure 9 | Distribution of the 9 dopaminergic neuron populations in the adult mouse 
brain. Reproduced with permission Björklund & Dunnett (2007). 
Dopamine plays a biological role in most multicellular organisms (Barron et al., 
2010). This is the case even for nematodes, which exhibit one of the simplest 
nervous systems, but still have dopaminergic neurons. The dopaminergic system 
is thought to be classically  involved in reward-motivation pathways, control of 
voluntary movements and endocrine hormone secretion (Harsing, 2008). 
However, the functions of a molecule so widespread within the animal kingdom 
are more diverse (Berg et al., 2013). 
The role of dopamine in disease, development and regeneration is the common 
denominator bringing papers I, II and III together, as well as this thesis. In paper I, 
we demonstrate that trifluoperazine, a dopamine receptor 2 (DRD2) antagonist, is 
 
 
48 
an inhibitor of glioblastoma growth. In paper II, we elucidate on the role of 
dopamine in development by studying the spatiotemporal developmental 
dynamics of the neural stem cells that give rise to dopaminergic neurons in the 
newt. We further show how ablation of the dopaminergic innervation affects 
neurogenesis in the forebrain as well as behaviour. In paper III, we extend our 
capacity to study the role of dopamine in regeneration by optimizing a tissue 
clearing method in order to quantify and trace dopaminergic neurites, as well as 
the radial extensions of newt neural stem cells. 
In this chapter we discuss dopamine’s role in disease, development and 
regeneration. 
7.1. The receptors 
The dopamine which acts on dopamine receptors is synthesized in the cytoplasm 
of cells, close to the synaptic terminals (Harsing, 2008). First, the aminoacid 
tyrosine is transformed into L-DOPA by the enzyme tyrosine hydroxylase (TH). 
Then, the enzyme DOPA decarboxylase converts L-DOPA into dopamine. 
Dopamine is then loaded into vesicles by vesicular monoamine transporters and 
released, so that it can interact with the DR. 
Five subtypes of DRs have been identified and constitute two families: D1-like 
(DRD1 and DRD5) and D2-like (DRD2, DRD3 and DRD4) (Missale, Nash, Robinson, 
Jaber, & Caron, 1998). The D1-like family is known to up regulate adenyl cyclase, 
while the D2-like family is known to down regulate it (Sibley & Monsma, 1992). Both 
families exert a regulatory effect on adenyl cyclase through their coupling to G 
proteins. D1-like family genes are intron-less (Missale et al., 1998), whereas D2-like 
family receptors have introns, which results in alternative splicing. Furthermore, 
DRD4 has polymorphisms in its coding sequence which results in a variable 
number of repeats in its third intracellular protein loop (Missale et al., 1998). 
The different subtypes of DRs are localized differently across the brain. The 
following localization list is adapted from a review from Strange and Neve (Strange, 
2013): 
§ DRD1: caudate/putamen, nucleus accumbens, olfactory tubercle, 
hypothalamus, thalamus, frontal cortex. 
§ DRD2: caudate/putamen, nucleus accumbens, olfactory tubercle, cerebral 
cortex. 
§ DRD3: nucleus accumbens, olfactory tubercle, islands of Calleja, putamen, 
cerebral cortex. 
§ DRD4: frontal cortex, midbrain, amygdala, hippocampus, hypothalamus, 
medulla. 
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§ DRD5: hippocampus, thalamus, lateral mamillary nucleus, striatum, cerebral 
cortex. 
7.2. In regeneration 
* The newt 
The newt is a fascinating animal model to study regeneration, as discussed in 
Chapter 2. Perhaps one day we will be able to cure neurodegenerative diseases 
by transferring these regenerative capacities to humans. This can only be achieved 
by the thorough understanding of the molecular processes that are involved.  
One of the most striking regenerative processes in the brain of one species of adult 
newts (Notophthalmus viridescens) is regulated by dopamine. This is the 
regeneration of the dopaminergic neurons in the ventral midbrain after 
dopaminergic lesion. The first step towards this finding was taken by Parish et al., 
who have created a Parkinson-like newt model by chemically ablating the 
dopaminergic system in the diencephalon and mesencephalon of the brain with 6-
OHDA (Parish et al., 2007). They demonstrated this lesion was effective by loss of 
DAPI, neuronal and dopaminergic markers. Full regeneration of the dopaminergic 
cell numbers occurred 30 days after neuronal ablation and this was accompanied 
by the recovery of locomotor activity. Particularly, the ventral midbrain of 
Notophthalmus is quiescent and, hence, no neurogenesis or proliferation of 
ependymoglial cells (progenitor cells in the newt) occurs in this region without 
injury. Thus, this demonstrates an unprecedented capacity for brain regeneration 
which has not been seen in post juvenile mammals to the same extent. This 
regenerative process is driven by de novo adult neurogenesis and was supported 
by the facts that after dopaminergic ablation: (i) The first cells to show incorporated 
BrdU were ependymoglial (progenitor cells in the newt); (ii) The progeny of 
ependymoglial cells migrated away from the ventricular layers and were positive 
for dopaminergic neuronal markers; (iii) Blocking of proliferation by administering 
cytosine arabinoside, reduced the number of new-born TH+ (dopaminergic) cells 
and the subsequent recovery in locomotion (Berg et al., 2010; Parish et al., 2007). 
This inherent capacity for regeneration in the adult newt brain raised questions on 
the distribution of the germinal niches across different brain regions, as these 
niches are known to fuel neurogenesis (Braun & Jessberger, 2014). Such question 
is especially relevant when considering the limited neurogenic capacity exhibited 
by mammals, as described in Chapter 4. Surprisingly, the distribution of germinal 
niches in homeostatic conditions is similar in the newt and in mammals (Berg et al., 
2010). Particularly, the adult newt forebrain displays proliferative and neurogenic 
activity in normal conditions, while the midbrain shows no proliferative activity, thus 
being a quiescent region. However, upon dopaminergic lesion, ependymoglial 
cells in the midbrain exit their quiescent state, start expressing the neuronal marker 
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NeuN and become Tyrosine Hydroxylase (TH, the rate limiting enzyme in the 
biosynthesis of dopamine) positive neurons, thereby achieving regeneration of the 
midbrain dopaminergic population. 
Msx1 is a transcriptional repressor that is needed in the development of midbrain 
dopaminergic neurons in mice (Andersson et al., 2006). The number of cells 
expressing this factor in the newt decreases in the ventral diencephalon and 
mesencephalon after dopaminergic lesion, followed by a progressive recover to 
normal values (Berg et al., 2010). This demonstrates Msx1 likely plays a role in the 
regeneration of TH+ midbrain neurons in the adult newt, in addition to its role in the 
homeostatic development of these neurons in mice. The similarities between this 
regenerative process in the newt and the developmental process in mammals 
raises the possibility of mammals retaining latent mechanisms for brain 
regeneration that could possibly be unlocked by external induction. Uncovering 
the processes in control of the activation of regenerative mechanism is key to the 
understanding how such findings can be transferred to a mammalian setting. 
Interestingly, the ligand Shh was found to be upregulated in the midbrain after 
dopaminergic lesion and blocking its expression inhibited regeneration (Berg et 
al., 2010). This factor was previously found to be involved in the specification of 
neural stem cells giving rise to midbrain dopaminergic neurons (Arenas, 2008; 
Kittappa, Chang, Awatramani, & McKay, 2007), as well as in the regulation of 
proliferation of neuronal/glial precursors (Traiffort, Angot, & Ruat, 2010). Shh has 
also been involved in newt regeneration, particularly in the limb and the lens. 
Another factor involved in the regeneration of midbrain dopaminergic neurons in 
the newt is dopamine. In fact, dopamine has been reported to control 
ependymoglia quiescence in a feedback mechanism fashion (Fig. 10; Berg et al., 
2011). In homeostatic conditions, and while the dopaminergic neuron population in 
the midbrain is present, dopamine inhibits the proliferation of ependymoglial cells 
as well as lesion-induced neurogenesis into dopaminergic neurons. Conversely, in 
dopaminergic lesion conditions, absence of dopamine results in activation of 
ependymoglial cells to proliferate, which in turn give rise to regenerative 
dopaminergic population to substitute the one that has been lost. These findings 
are strengthened by the fact ependymoglial cells express the DRD1 and DRD2 
receptors and are thus sensitive to dopamine signalling regulation. Furthermore, 
administration of L-DOPA, a dopamine precursor used as dopamine replacement 
therapy in PD, result in inhibition of ependymoglia proliferation and subsequent 
regenerative response. This finding highlights the mechanistic requirement of 
dopamine depletion for neural stem cell activation. In line with these findings, 
blocking of the dopamine signalling in normal homeostatic conditions with a 
dopamine antagonist, haloperidol, activates ependymoglia proliferation and leads 
to genesis of an above-normal number of developing and mature dopaminergic 
neurons. 
 51 
 
Figure 10 | Model of control of quiescent ependymoglia 
proliferation in the newt brain by dopamine. If dopamine is 
depleted due to the ablation of dopaminergic neurons, the 
ependymoglial cells in the ventricular zone are activated from a 
quiescent state and lead to a regenerative response of the lost 
neurons. Adapted from Berg (2011). 
Taken together, adult newts possess a capacity for activation of brain regeneration 
processes out of a quiescent state, thereby achieving full regeneration of the 
midbrain dopaminergic neuron population. This is however not the case of PD 
patients, who do not natively regenerate the dopaminergic neurons which are lost 
in the SNc in the course of this disease. Cross-species studies are therefore 
paramount for the understanding of the biological differences which are key to 
regenerative capacities. 
* Mammals 
Dopamine has been implicated in proliferation regulation in the mammalian brain 
(Berg et al., 2013) and this control was observed mainly in the SVZ neurogenic 
niche of the forebrain of adult mice (Chapter 4). Cells in this niche express 
dopamine receptors (C-cells, D2-like receptors and A-cells, D1-like and D2-like 
receptors) and are innervated by dopaminergic fibres which have their cell bodies 
in the SNc (Freundlieb et al., 2006; Höglinger et al., 2004). If these dopaminergic 
cell bodies in the SNc are ablated, and with them the release of dopamine to the 
SVZ, then the proliferation of progenitor cells in the SVZ is decreased, as well as 
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neurogenesis (Baker, Baker, & Hagg, 2004; Höglinger et al., 2004; L’Episcopo et 
al., 2014; Winner et al., 2009). Dopamine receptor agonists have been shown to 
rescue proliferation as a consequence of lack of dopamine release (Höglinger et 
al., 2004; Winner et al., 2009; P. Yang, Arnold, Habas, Hetman, & Hagg, 2008), 
while another study reports a similar effect with the dopamine receptor antagonist, 
haloperidol (Kippin, Kapur, & van der Kooy, 2005). Berg and colleagues proposed 
that these contradictory findings could be explained by dopamine having an anti-
proliferative effect on neural stem cells but pro-proliferative effect on transit-
amplifying cells (Berg et al., 2013). As neural stem cells can divide less frequently 
than transit-amplifying cells then perhaps only long-term studies can uncover the 
anti-proliferative effect of dopamine receptor antagonists acting on them. 
7.3. In development 
Understanding the ontogeny of dopaminergic neurons in the brain is necessary in 
order to be able to artificially recreate this process for clinical purposes. How do 
the different dopaminergic neurons occupy their right positions? Which factors 
regulate their development? How do they acquire their dopaminergic phenotype? 
A vast amount of research on the ontogeny of dopaminergic neurons has focused 
on the ventral midbrain populations (A8-A10). This is due to interest in the 
degenerative processes of the dopaminergic populations of the ventral midbrain 
in Parkinson’s disease, particularly in the VTA and the SNc (Alberico, Cassell, & 
Narayanan, 2015). The hope is that, by better understanding the ontogeny of these 
neurons, one will be capable of recapitulating its identity in cell replacement 
therapies, which are aimed at the treatment of neurodegenerative diseases (R. A. 
Barker, Parmar, Studer, & Takahashi, 2017; Kikuchi et al., 2017). 
* Development of the ventral midbrain dopaminergic neurons 
A midbrain dopaminergic neuron is born through a complex series of molecular 
cascades and feedback loops, some of which are still not fully understood. Three 
main phases can be generally recognized: (i) the early patterning of the ventral 
mesencephalon; (ii) acquisition of a dopaminergic phenotype by the ventral 
midbrain neural precursors; (iii) development of post-mitotic dopaminergic neurons 
in the ventral midbrain. For better understanding we present detailed diagrams for 
each phase of development of the ventral midbrain dopaminergic neurons, based 
on the review texts by Hegarty and colleagues (Hegarty, Sullivan, & O’Keeffe, 
2013). These are in a time organized fashion, with events happening later being 
shown lower on axis of the main cascade and events happening earlier are shown 
higher. These diagrams are annotated for which factor induces/represses each 
molecular event, as well as for the mouse developmental stage correspondent to 
these events. These annotations are also performed for pathways that are 
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suspected to be involved but for which there is not yet enough scientific evidence 
to establish a correlation yet. We briefly discuss the highlights of the 3 phases of 
development of the ventral midbrain dopaminergic neurons below. 
During the early patterning of the ventral mesencephalon the dorsal ectoderm 
gives rise to the neural plate which, upon closing of this structure, becomes the 
neural tube. In the neural tube two structures are formed that are later required for 
the genesis of dopaminergic neurons: the floor plate and the isthmus organizer 
(Fig. 11). The floor plate will be the source for the dopaminergic neural precursors, 
while the isthmus organizer is involved in the regional specification of the ventral 
midbrain. The isthmus organizer is placed at the right anatomical position by a 
positional repression of Otx2 and Gbx2 against each other. The isthmus organizer 
then expresses secondary transcription factors: Pax2, Lmx1b, Wnt1 and En-1. Wnt1 
and En-1 induce FGF8 and, in this manner, refine the position of the isthmus. All of 
the secondary transcription factors here mentioned contribute to the regional 
specification of the ventral midbrain. En-2 and Pax5 have also been found to play 
a role in this process. 
The second phase in the development of the dopaminergic neurons of the ventral 
midbrain is the induction of a dopaminergic phenotype (Fig. 12). Here, floor plate 
radial glia-like neuronal precursors, which are positive for Vimentin, BLBP and 
GLAST, start expressing Shh. Shh then participates in a molecular cascade with 
Gli1/2/3, ending up in the induction of FoxA2. In turn FoxA2 induces the expression 
of proneural protein NGN2 and Lmx1a/b. Lmx1a then induces Msx1 which further 
induces NGN2. Lmx1a and Msx1 are determinants of midbrain dopaminergic 
neurons and have been found to be required for differentiation into dopaminergic 
neurons (Andersson et al., 2006). Wnt signalling also plays an important role in the 
induction of a dopaminergic phenotype. It does so by inducing Lmx1a and FGF8, 
and by repressing Shh which in turn blocks dopaminergic neurogenesis for the 
time being. This blocking of dopaminergic neurogenesis is lifted later at 
developmental stage E12. Lmx1a has also been found to induce Otx2, which then 
regulates proliferation of dopaminergic neural precursors. 
The last and third phase in the development of dopaminergic neurons of the 
ventral midbrain is the development of post-mitotic dopaminergic neurons (Fig. 13). 
After the neuronal precursors in the floor plate have acquired a neuronal 
phenotype, culminating in the induction of NGN2, these cells will start to express 
TH, gradually stop mitosis and migrate to their respective position in the SNc and 
VTA. First, ventral migration takes place, along tenascin-expressing radial glia. 
Second, lateral migration takes place, along L-1 expressing tangentially oriented 
fibres. Eventually migration halts once the cells are at their respective positions. 
The factors involved in the regulation of the end of migration are not yet known. 
After the stop of migration several transcription factors which contribute to 
differentiation and survival of the ventral midbrain dopaminergic neurons are 
expressed: Lmx1b, Nurr1, Pitx3 and En-1/En-2. The respective pathways induced by 
these transcription factors are represented in the diagrams of Fig. 13 and Fig. 14. 
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Figure 11 | Cellular and molecular events in the early patterning of the 
ventral mesencephalon. These processes are involved in the 
development of the dopaminergic neurons in the ventral midbrain. 
Lmx1a+ cells arise during embryonic development but they remain in the midbrain 
of the adult even after the neurogenic process has finished (Hedlund et al., 2016). 
These cells, however, decrease in number and their fibre projections become 
shorter as the adult ages. Interestingly, lmx1a+ cells in the midbrain were found to 
express DRD2. Additionally, the brain region where they are located is innervated 
by midbrain dopaminergic neurons. If embryonic mice (E12-E17.5) are treated with 
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the dopamine antagonist haloperidol then proliferation of Lmx1a+ cells is increased, 
as well as dopaminergic neurogenesis. Furthermore, a similar effect on 
proliferation and neurogenesis was observed in mouse embryonic midbrain cell 
cultures with haloperidol and another dopamine receptor antagonist, sulpiride. 
Taken together, dopaminergic antagonists seem to be in control of proliferation of 
Lmx1a+ neuronal progenitors which are committed to differentiation into 
dopaminergic neurons, after the neurogenic period of these neurons has ended. 
The question remains on whether it is possible to induce a similar neurogenic 
process in the ventral midbrain of the adult mouse. 
 
 
Figure 12 | Cellular and molecular events in the induction of a dopaminergic 
phenotype. These processes are involved in the development of the ventral 
midbrain dopaminergic neurons. 
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Figure 13 | Cellular and molecular events involved in the development of post-mitotic 
dopaminergic neurons in the ventral midbrain. 
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Figure 14 | Molecular events of Pitx3 and En-1/En-2 during the development of 
post-mitotic dopaminergic neurons in the ventral midbrain. 
7.4. In disease 
7.4.1. Parkinson’s disease 
Epidemiological studies report PD has the second most common 
neurodegenerative disease, after Alzheimer’s disease (Ascherio & Schwarzschild, 
2016). PD is characterized by slow movement (bradykinesia), postural imbalance, 
tremors upon resting and rigidity. Earlier, non-motor related symptoms, have also 
been associated with PD. These are: anxiety, depression, cognitive impairment, 
decrease in olfaction and dysfunction of the autonomic nervous system (Winner & 
Winkler, 2015). 
PD symptoms are believed to be linked to the degeneration of dopaminergic 
neurons in the SNc of the ventral midbrain, together with the degeneration of 
dopaminergic forebrain innervation where VTA and SNc dopaminergic cell bodies 
project to (Höglinger et al., 2004; Winner & Winkler, 2015). Some degeneration of 
the VTA dopaminergic population has also been reported in PD patients, although 
this degeneration is less extensive than the one observed in the SNc (Alberico et 
al., 2015). A hallmark of the degeneration of dopaminergic neurons in PD is the 
intracellular deposition of alpha-synuclein in abnormal protein aggregates, Lewy 
bodies (Spillantini et al., 1998). 
* Impact of dopaminergic degeneration in the ventral midbrain 
As discussed in Chapter 4 the SVZ of the lateral ventricles and the DG of the 
hippocampus contain NSPCs with neurogenic potential. These niches are 
innervated by dopaminergic fibres from three dopaminergic cell populations in the 
ventral midbrain, two of which have been shown to degenerate with the 
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progression of PD (Höglinger, Arias-Carrión, Ipach, & Oertel, 2014). In mice, the SNc 
dopaminergic neurons of the ventral midbrain were found to project to the SVZ as 
well as to the RMS. Whereas, the VTA dopaminergic neurons innervate the SVZ 
alone. The SVZ is adjacent to the striatum and the nucleus accumbens, which both 
receive dopaminergic afferents from the three ventral midbrain dopaminergic 
groups (SNc, VTA and retrorubral fields; A8-A10). Both the SNc and the VTA 
dopaminergic neurons project to the DG of the hippocampus. In macaques, the 
SNc dopaminergic neurons, but not the ones from the retrorubral field, were also 
found to project to the SVZ (Freundlieb et al., 2006). 
As the dopaminergic neurons in the ventral midbrain project to two of the three 
neurogenic niches, what is the impact of dopaminergic fibre degeneration on 
neurogenesis, such as it happens in PD? In the SVZ of mice, Höglinger and 
colleagues have shown proliferative precursors express dopamine receptors, 
meaning they can potentially respond to dopamine signalling (Höglinger et al., 
2004). The same study demonstrates that, in PD mouse models, generated by 
dopaminergic lesion with MTPT, decreased proliferation levels were observed in 
the precursor cells of the SVZ and DG. Furthermore, in the SVZ, the cells which 
exhibited this lower proliferation are EGFR positive. The effect of dopaminergic 
lesion on proliferation is rescued by ropinirole, a D2-like agonist. Höglinger et al. 
also report similar findings in PD patient samples. In these patients, the SVZ has 
lower numbers of proliferating cells and in the DG and olfactory bulb the numbers 
of neural precursor cells are also lower than in the controls. Freundlieb and 
colleagues performed a similar study in PD macaque models (Freundlieb et al., 
2006). They find that, after dopaminergic denervation, lower numbers of 
proliferating cells as well as neuroblasts were found in the SVZ. A later study 
elucidated on the molecular mechanisms involved in the control of proliferation by 
dopaminergic fibres (O’Keeffe et al., 2009). In mice, dopaminergic fibres release 
EGF at the SVZ, which then activates the EGFR to induce proliferation of SVZ 
precursor cells. Interestingly, the same study demonstrates dopamine also has the 
capacity to control self-renewal of stem cell populations which are positive for 
GFAP. Taken together, these findings implicate dopaminergic fibre degeneration 
and a PD phenotype in a lower proliferation capacity at the SVZ and DG neurogenic 
niches. This can in turn represent the occurrence of lower neurogenic levels in PD 
patients. In accordance to the findings above, O’Keefe et al. also find a decreased 
number of EGFR+ cells in PD patients. This means that not only is the dopaminergic 
signalling towards stimulation of proliferation decreased in PD but also the capacity 
to receive these signals. 
However, the impact of the dopaminergic degeneration in the ventral midbrain in 
proliferative changes of neurogenic niches is still controversial. Indeed, Berge et 
al. reported opposite results when finding no decrease in neural stem cell number 
or in proliferation between PD and control groups (Van Den Berge et al., 2011). 
Likewise, the same study found no effect on precursor cell proliferation in PD mice 
models. Winner and Winkler propose these contrasting findings could be due to 
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the use of samples with different post mortem times, differences in the region of 
the SVZ that was analysed or the use of distinct proliferation markers. 
* Adult dopaminergic neurogenesis in the substantia nigra 
On the topic of whether adult dopaminergic neurogenesis occurs in the substantia 
nigra, several studies have reported opposite results. First, progenitor cells have 
been identified in the adult substantia nigra but show no capacity to differentiate 
into neurons in vivo possibly due to the lack of the right environmental signals (Lie 
et al., 2002). Second, Zhao et al. brought forward evidence on the generation of 
very low numbers of dopaminergic neurons in the substantia nigra of rodents, with 
an increase in the neurogenic level after MPTP-induced dopaminergic lesion (M. 
Zhao et al., 2003). Shan et al. report similar findings with increased dopaminergic 
neurogenesis in the substantia nigra, with origin on neural precursor cells, after 
MPTP lesion (Shan et al., 2006). However, another study reports contradictory 
results by showing that in a mouse model with 6-OHDA-induced dopaminergic 
lesion, there is no sign of neurogenesis of new dopaminergic neurons or migration 
of neural stem cells to the substantia nigra (Frielingsdorf, Schwarz, Brundin, & 
Mohapel, 2004). In normal and PD human tissue, similar findings were obtained, 
with no evidence for newborn neurons in the substantia nigra (Höglinger et al., 
2007). Taken together, the notion of no occurrence of adult dopaminergic 
neurogenesis in the substantia nigra remains stronger, although the topic remains 
highly controversial. 
* Cell replacement therapies 
A type of exogenous cell replacement therapy, the intrastriatal transplants of 
dopaminergic neuron grafts, have been performed in PD patients with the aim of 
alleviating the symptoms caused by dopaminergic neuron degeneration (Lindvall 
& Bjorklund, 2004; Lindvall et al., 2004). These clinical studies made use of foetal 
mesencephalic tissue for transplantation. The dopaminergic neurons in this tissue 
successfully integrated in the target striatum, restored dopamine release and 
provided some degree of functional and movement-related recovery. However, a 
couple of drawbacks afflicted these studies: (i) the difficulty in obtaining foetal brain 
tissue and ethical constraints involved make it difficult for such a clinical approach 
to be available for a large cohort of PD patients; (ii) the degree of achieved recovery 
was considerably variable among patients; (iii) dyskinesia side effects which 
occurred in a large proportion of patients. Due to the development of iPSC cells 
we can now derive dopaminergic neurons from somatic cells, thereby removing 
one of the difficulties involved in the undertaking of exogenous cell replacement 
therapies in PD. Furthermore, Kikuchi et al. successfully performed pre-clinical 
studies involving the transplantation of iPSC-derived dopaminergic progenitor cells 
into the midbrain of macaque PD models (Kikuchi et al., 2017). They show that these 
neurons maturated into dopaminergic neurons and their neurites projected to the 
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striatum. Additionally, movement recovery was achieved and no tumours were 
formed parallel to graft survival for up to 24 months. This study is the first step 
towards the human trials of iPSC-derived dopaminergic neurons in PD, which have 
already started, at the time of writing of this thesis (R. A. Barker et al., 2017). These 
trials, which take place concurrently in several countries, are aggregated under the 
umbrella organization GForce-PD (www.gforce-pd.com). 
7.4.2. Cancer 
7.4.2.1. Glioblastoma 
Brain tumour incidence was found to be reduced in patients with neuropsychiatric 
disorders, such as PD and schizophrenia (Diamandis, Sacher, Tyers, & Dirks, 2009; 
Olsen et al., 2005). One explanation for this would be the neuropharmacological 
drugs which are taken by these patients, such as the dopamine precursor L-DOPA, 
to have an inhibitory effect towards brain tumour development. Indeed, dopamine 
receptor signalling was found to be involved in the proliferation and survival of 
glioblastoma neural stem cells (GNS) (Dolma et al., 2016). Such findings are in line 
with the capacity of dopamine receptor antagonists to induce proliferation and 
control fate of normal neural stem cells (Berg et al., 2011; Dolma et al., 2016; 
Hedlund et al., 2016), although in GNS dopamine receptor antagonists seem to act 
rather through an anti-proliferation mechanism (Dolma et al., 2016; Karpel-Massler 
et al., 2015). Dolma et al. investigated the mechanisms by which dopamine 
signalling is inhibitory to GNS. In this study, they screened GNS, NSC and fibroblast 
lines with 680 neuroactive compounds in proliferation assays. They found 
dopaminergic compounds to represent the largest class of hits which are selective 
for GNS. After a secondary screening, they showed that 2 of the 3 most selective 
hits for GNS are DRD4 antagonists: PNU 96145E and L-741,742. These two DRD4 
antagonists reduced GNS cell viability and reduced the clonogenic capacity of 
primary glioblastoma (GBM) cells, with a mild reduction effect on the cell viability 
of normal NSC. Particularly, the DRD4 antagonist L-741,742 induced differentiation 
of neural stem cells, in line with previous studies with other DRD4 antagonists (Berg 
et al., 2011; Hedlund et al., 2016). Of particular clinical value, both DRD4 antagonists 
were found to act synergistically with the most common therapeutic agent for 
glioblastoma, temozolomide. Dolma and colleagues also showed the DRD4 
receptor in GNS to be functional and that its functional loss by short hairpin RNA 
knockout lead to reduced proliferation. Interestingly, the inhibitory effect on GNS 
by DRD4 antagonists seemed to be due to an impairment of autophagic-flux 
mediated by inhibition of DRD4 signalling. Other effects of these DRD4 antagonists 
on GNS cells were the disruption of the PDGFRb-ERK1/2 pathway and mTOR 
signalling as well as the triggering of G0/G1 cell cycle arrest and apoptosis. This 
effect was observed both in in vitro cell lines and in vivo tumours. Lastly, DRD4 
antagonists were also found to increase survival in mice. Taken together, DRD4 
 61 
antagonists are strongly implicated in the inhibition of glioblastoma growth and 
some of the molecular mechanisms involved in this response are now understood. 
Another study identified Olanzapine, a DRD2 antagonist, as inhibitory of 
proliferation and migration in GBM cell lines (Karpel-Massler et al., 2015). In 
similarity to DRD4 antagonists, this DRD2 antagonist acted synergistically with the 
chemotherapeutic agent temozolomide. Another study showed a cell viability 
inhibition effect on long term passaged GBM cell lines and GNS by DRD2 
antagonists: spiperone, haloperidol, risperidone and L-741,626 (J. Li et al., 2014). In 
accordance to the findings discussed above, dopamine itself was found to inhibit 
glioma cell proliferation as well as to induce apoptosis through the activation of 
mitochondrial pathways (Lan, Wang, Xing, Yu, & Lou, 2017).  
From a prognostic perspective, data from the Cancer Genome Atlas (TCGA) 
correlates both higher DRD4 and also TH expression in GBM with worse survival 
(Dolma et al., 2016). Furthermore, the expression of DRD1, DRD2 and DRD5 was 
found to be reduced in GBM in the same database (Caragher et al., 2017). 
Contrastingly to DRD4, the expression of all the remaining DR subtypes was found 
associated with a survival benefit in GBM patients. 
In paper I, we show that a DRD2 antagonist, trifluoperazine, inhibits glioblastoma 
cell line growth and survival differently in cell lines expressing dissimilar DR 
expression profiles. These findings are further discussed in Chapter 8. 
7.4.2.2. Other cancer types 
Dopamine signalling has been found to have a regulatory effect in other tumour 
types than glioblastoma. A general (DRD1-DRD5) dopamine receptor antagonist, 
thioridazine, was found to prevent initiation of acute myeloid leukaemia by 
targeting dopamine receptors in human somatic cancer stem cells (Sachlos et al., 
2012). In a review by Rubi and Maechler, the effect of dopamine and its 
antagonists/agonists on cancerous cells is discussed. Reportedly, dopamine and 
dopamine agonists were shown to impair cell growth or slow tumour growth in 
small lung cancer, meningioma, B cells from lymphoid malignancy and gastric 
cancer (Rubí & Maechler, 2010). In breast and colon tumours dopamine seems to 
increase the efficiency of anticancer drugs. Furthermore, dopamine was shown to 
stabilize tumour blood vessels, which is necessary to improve drug delivery and 
prevent worsening of tumour hypoxia, a factor increasing resistance to cancer 
drugs (Chakroborty et al., 2011). 
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8. Present investigations 
8.1. Paper I – dopamine and disease 
The aim of this study was to evaluate the effect of dopamine ligands and their 
receptors in the inhibition of GBM proliferation and survival. 
* Summary of results 
We hypothesized dopamine signalling to have a regulatory effect on glioblastoma 
proliferation and survival based on: (i) the similarities of stem cell regulation in 
homeostasis, regeneration and in cancer; (ii) the capacity of dopamine signalling 
to control the growth of other cancer types; (iii) how dopamine influences neural 
stem cell quiescence in the brain, as for example in the regenerative process of 
dopaminergic neurons in the ventral midbrain of the newt. Please refer to Chapters 
6 and 7 for further details on these topics. 
To identify dopamine signalling compounds capable of modulating metabolic 
activity in GBM we screened three primary GBM cell lines, U3005MG, U3028MG 
and U3046MG, with a library of 80 dopaminergic ligands. These specific cell lines 
were selected for this study due to their diverse dopamine receptor expression 
profiles. In this primary screening, we find 45 metabolically active compounds. Of 
these, 42 resulted in a decrease and 3 in an increase in GBM cell viability. We also 
observed some of these compounds to be active in certain GBM cell lines but not 
in others, while other compounds showed a strong inhibitory effect in all studied 
GBM cell lines. This suggested a selective effect of some dopamine ligands to 
specific GBM cell lines. 
In order to further validate these findings, 8 out of the 45 identified compounds 
were selected for further screenings. Concentration-response curves were then 
run on: (i) 2 of the 3 compounds found to promote cell viability; (ii) 6 of the 42 
compounds found to inhibit cell viability. We found that the cell viability promoting 
compounds showed no effect in these concentration-response curves. We also 
considered 5 of the 6 tested inhibitory compounds to be acting through cytotoxic 
non-selective mechanisms, based on their EC50 values and the shape of their 
dose-response curves. However, a DRD2 antagonist, trifluoperazine 2HCl 
displayed an effective inhibition of cell viability of GBM cell lines in a dose 
dependent manner. We also find this dopamine ligand to have a selective inhibitory 
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effect on U3005MG and U3046MG, while U3028MG showed some resistance to 
this inhibition at lower concentrations.  
The 3 GBM cell lines in this study express different profiles of DR subtypes, specific 
to each cell line. We asked whether trifluoperazine 2HCl, being a DRD2 antagonist, 
targets GBM cell lines differently based on their expression of DR subtypes. We 
therefore validated the expression levels of DRD1, DRD2 and DRD3 in the GBM cell 
lines of this study and compared this with the values reported in the Human 
Glioblastoma Cell Culture (HGCC) resource. We find the expression levels to be in 
accordance to the HGCC reported levels, demonstrating our cells have not 
substantially changed during the course of our experiments and are therefore 
representative of their dopamine receptor expression profiles. In summary, these 
cell lines have the following relative expression values: (i) U3005MG has high 
DRD2 and DRD5; (ii) U3028MG has high DRD1, DRD4 and DRD5; (iii) U3046MG has 
low of DRD1-DRD5 (all subtypes). 
Metabolic based assays, as used in the primary and secondary screenings of this 
study, are not a direct indication of changes in cell proliferation. Therefore, we 
performed nucleotide analogue EdU based assays to assess proliferation changes 
upon treatment with trifluoperazine. We find the GBM cell line U3028MG to retain 
some base line proliferation levels 73h after the treatment with the highest 
concentration of trifluoperazine. However, U3005MG proliferation rate dropped 
sharply or could not be calculated in U3028MG due to a considerable amount of 
dying cells. In accordance, U3028MG total cell number is found unaltered at the 
highest concentration of trifluoperazine treatment, showing this drug inhibits 
proliferation but does not lead to cell death. 
We conclude trifluoperazine 2HCl’s inhibition of GBM cells is cell line dependent 
and correlates with variations in the DR expression profile of these cell lines. 
* Discussion 
From our screening of 80 dopaminergic ligands we have identified and validated 
a DRD2 antagonist, trifluoperazine, to have an inhibitory effect on GBM cell lines. 
This compound has been linked to cancer inhibition in several studies and this 
inhibition has been linked to several pathways, including DRD2 signalling. First, 
trifluoperazine inhibits GBM invasion in a calcium signalling mediated manner 
(Kang et al., 2017). In another GBM study, trifluoperazine is demonstrated to inhibit 
proliferation of U87MG GBM cell line after EGR-1 upregulation (Shin, Kim, Hong, 
Kim, & Lee, 2004). Furthermore, in a lung cancer setting, this compound inhibits 
cancer stem cell growth and overcomes drug resistance (Yeh et al., 2012). In yet 
another study, trifluoperazine reduces angiogenesis and prevents metastasis of 
human prostate cancer cell lines, with these effects being linked to DRD2 signalling 
which is believed to act in this context through a DRD2-AKT-ß-catenin network 
(Pulkoski-Gross et al., 2015). Upon screening for GBM inhibiting compounds, Dolma 
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and colleagues identified trifluoperazine, together with another DRD2 antagonist, 
thioridazine, as hits (Dolma et al., 2016). Moreover, concurrent inhibition of DRD2 
and EGFR signalling leads to an anti-tumour effect in in vitro and in vivo 
glioblastoma settings (J. Li et al., 2014). Taken together, the findings of paper I and 
previous research suggest trifluoperazine’s inhibition of GBM growth may act 
through DRD2 signalling but also through additional mechanisms. 
Interestingly, the GBM cell line that shows the highest resistance to trifluoperazine, 
U3028MG, is also the one with the highest expression level of all DR subtypes 
together. Perhaps the D2-like receptor subtypes (DRD2, DRD3 and DRD4) act in 
synergy with each other as all of these are known to down regulate adenyl cyclase. 
We also observe U3028MG has the highest expression levels of DRD4 out of the 
3 tested GBM cell lines. Dolma and colleagues have elucidated a mechanism for 
GBM inhibition in vitro and in vivo which acts through DRD4 signalling (Dolma et 
al., 2016). In this study the DRD4 antagonists L-741,742 and PNU 96415E disrupt 
the autophagy-lysosomal pathway, specifically in GNSs and not in NSCs, in this 
manner inhibiting proliferation and survival of GNS. 
The results from paper I as well as previous studies indicate trifluoperazine as a 
potential candidate for treatment of GBM. Moreover, some of the compounds on 
the primary screening of this study were not further validated and thus could be 
additional candidates in the context of dopamine signalling inhibition of GBM. 
* Study limitations 
Some of the limitations of paper I are: 
§ No mechanism has been elucidated to explain trifluoperazine’s inhibition of 
cell proliferation and survival through DRD2 in a GBM setting. In prostate 
cancer trifluoperazine has been shown to act on DRD2 through a DRD2-
AKT-ß-catenin network but this has not been validated in a GBM context or 
in in vivo experiments (Pulkoski-Gross et al., 2015). 
§ Trifluoperazine’s effect on glioblastoma has not been tested in vivo, 
meaning its inhibititory activity may or may not reproduce itself in this 
setting. 
§ Sinergestic effects between DR subtypes need further clarification in a 
cancer context. 
§ Many of the dopamine ligands which were introduced in the primary and 
secondary screening have shown no effect on inhibition of GBM cell lines. 
This may represent different acting mechanisms by similar dopamine 
agonists/antagonists or raise concerns about its specificity. 
§ It can not be excluded that trifluoperazine acts through a non-DRD2 
pathway during inhibition of GBM proliferation and survival. 
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8.2. Paper II – dopamine and development 
The aim of this study was to provide a new evolutionary perspective on the origin 
of adult neural stem cells, brain maturation and acquisition of associated 
behaviours. This work was also aimed to evaluate the dynamics of dopaminergic 
neurogenesis during development and the consequences of dopaminergic 
neuronal ablation at the cellular and behaviour level. 
* Summary of results 
This study made use of two newt species, Notophthalmus viridescens and 
Pleurodeles waltl. Due to different body sizes of these animals at the juvenile and 
adult stages it was unclear whether their brain size would also differ. Indeed, in 
absolute size the brain of Pleurodeles is bigger than the one of Notophthalmus but 
if this measurement is undertaken as a ratio to body size then the Notophthalmus 
brain is instead bigger. 
By studying cell proliferation in the brain of these two species we found the 
following similarities: (i) The marker combination Sox2+/GFAP+ characterizes the 
main proliferative population; (ii) Quiescent regions appear in a caudal-to-rostral 
fashion across development. 
We also find the following differences in cell proliferation between species and 
brain regions: (i) proliferation rates are generally higher across Pleurodeles brain 
regions during development; (ii) Notophthalmus has more regions becoming 
quiescent by adulthood than Pleurodeles. 
Proliferating ependymoglial cells in the ventricular zone of the Notophthalmus 
brain are considered to be the source of new neurons (Kirkham et al., 2014). 
Ependymoglia can be of two types: (i) type-1, GFAP+/GS+ and the main proliferating 
type in quiescent “non-hotspot” regions; (ii) type-2, GFAP+/GS- and the majority of 
the progenitors in proliferating “hotspot” regions. We find that in Pleurodeles and 
at early developmental stages, all the ependymoglial cells in the VZ and SVZ are 
of type-2. Type-1 cells arise later during brain maturation. We also correlated the 
appearance of type-2 cells with the appearance of structures responsible for the 
anatomical separation of brain regions, sulci. These data indicated ependymoglia 
distribution to differ from previous observations in the adult Notophthalmus brain. 
Specifically, in adult Pleurodeles, in addition to developmental 
Notophthalmus/Pleurodeles, type-2 cells correspond to the main proliferating 
population in all brain regions, instead of only the “hotspot” regions. Experiments 
with conditional reporter transgenic newts are in support of these findings. Here, 
type-1 cells give rise to small clone groups in the brain parenchyma, arguing for 
their quiescent state. Contrastingly, type-2 cells are found in large groups in the 
brain parenchyma, arguing for their proliferative state. 
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We hypothesized the acquisition of quiescence could be linked to variations in cell 
cycle length in different brain regions. We then measured cell cycle length at a 
population level by sequential injection of EdU/BrdU nucleotide analogues 
(Martynoga, Morrison, Price, & Mason, 2005; Nowakowski, Lewin, & Miller, 1989). 
For initial larvae we find that the cell cycle is longer in Pleurodeles than in 
Notophthalmus in all studied brain regions. For late larvae, the regions that were 
in the process of becoming quiescent accumulated slowly cycling cells. 
Particularly, the cell cycle length of the pallium is longer in Pleurodeles than in 
Notophthalmus. In accordance, the telencephalon of Notophthalmus becomes 
quiescent at a later stage than in Pleurodeles. We also measured cell cycle length 
at a cellular level by using transgenic Nucbow and Cytbow salamanders, created 
with the aid of the Multi-addressable genome-integration colour (MAGIC) method 
(Loulier et al., 2014). This method works by inducing a one-time recombination that 
leads to the expression of the same fluorescent protein by both the recombined 
cell and its upcoming progeny. We find that clones in quiescent areas remained 
local and in low absolute numbers, whereas clones in expanding regions had 
higher cell numbers, some of which spread into the mantle zone. Taken together, 
these results confirm type-1 ependymoglia are slow diving progenitor cells. 
We then asked how neurogenesis is spatially and temporally regulated in the 
developing newt brain. We answer this by first analysing the expansion of the 
Pleurodeles telencephalon with markers for ependymoglial cells (Sox2), for mature 
neurons (NeuN) and EdU pulse chase experiments. We observe brain regions 
reach maturation in the following order: striatum and medial pallium, lateral and 
ventral pallia, dorsal pallium and pallidum. After performing similar experiments in 
the Notophthalmus brain, we show that, in both species, highly neurogenic areas 
correlate with highly proliferative areas across developmental stages and brain 
regions. We further demonstrate the following correlations between the 
appearance of specific behaviours and the development of specific 
neuroanatomical features: (i) a mix of locomotor and feeding behaviours is 
associated with the maturation of the striatum and the medial pallium region; (ii) 
the active hunting-foraging behaviour, first use of olfaction and motivationally 
mediated locomotion is associated with the thickening of the fibre zone; (iii) 
olfaction-driven exploratory and feeding behaviour is associated with the rise of 
NeuN+ cell numbers in the dorsal pallium and the pallidum. 
Next, we set to examine the dopaminergic and cholinergic neurogenesis across 
development. We find suggestive evidence of the following: (i) the ventral midbrain 
dopaminergic cells arise first from caudal-most regions; (ii) dopaminergic and 
cholinergic neurogenesis slows down but still takes place in juvenile stages; (iii) 
Pleurodeles have higher dopaminergic cell numbers than Notophthalmus during 
development and in adulthood; (iv) Pleurodeles males have more dopaminergic 
neurons in some brain regions, while no sex-based difference is observed in 
Notophthalmus. 
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We also investigated the role of dopaminergic neurogenesis during development 
by performing dopaminergic ablations followed by behavioural testing. This 
procedure ablated the dopaminergic neurons of the ventral midbrain as well as its 
ventral midbrain-to-striatum projections. We find evidence of the following: (i) 
forebrain dopaminergic innervation is involved in cognitive function related to 
learning, fear and decision-making; (ii) a regenerative response of the ventral 
midbrain dopaminergic neurons during Pleurodeles development; (iii) striatal 
proliferation is decreased in animals where the ventral midbrain-to-striatum 
pathway has been lesioned; (iv) shorter cell migratory distances in the striatum 
region support the effect of dopaminergic lesion on cell proliferation. 
* Discussion 
These results provide a descriptive analysis of the processes involved in brain 
maturation in two newt species: Notophthalmus and Pleurodeles. This analysis was 
performed at the different levels: cell proliferation, ependymoglial cell maturation, 
neurogenesis (general and of specific subpopulations) and acquisition of 
behaviours. 
One of the findings was that proliferative regions are not conserved in two newt 
species. This is interesting since in the adult axolotl proliferation was found to be 
present in many regions (Amamoto et al., 2016; Maden, Manwell, & Ormerod, 2013; 
Richter & Kranz, 1981), while the adult Notophthalmus brain is largely quiescent 
(Berg et al., 2010). Our data indicates the proliferation dynamics of the Pleurodeles 
brain during development to more closely resemble the axolotl and teleost fishes. 
This provides one more evolutionary perspective to brain ontogeny of vertebrates. 
Interestingly, in our study, proliferating cells are restricted to the VZ and SVZ of the 
newt brain, just as in other vertebrates (D’Amico, Boujard, & Coumailleau, 2011; 
Garcı a-Verdugo et al., 2002; Lam, März, & Strähle, 2009; Lin et al., 2015; Montiel 
& Aboitiz, 2015; Moreno & González, 2017). We also show Notophthalmus and 
Pleurodeles brain development to have similarities to other tetrapods. This is 
evident as the cell cycle length slows down at later developmental stages in both 
cases (Thuret, Auger, & Papalopulu, 2015; Watanabe, Kageyama, & Ohtsuka, 2015). 
In addition, in this study the S-phase of newts was also found to have similar length 
to tetrapods (Caviness, Takahashi, & Nowakowski, 1995; Thuret et al., 2015). 
In terms of ependymoglia maturation this study presents evidence for type-1 
ependymoglia to appear during developmental stages after type-2 cells. 
Furthermore, type-1 cells appear in increasingly quiescent regions and have longer 
cell cycles. These data provide new insights into the developmental origin of 
ependymoglia types in the adult newt brain. This is important also in the context 
these cells play an important role in the regeneration of the ventral midbrain 
dopaminergic neurons in the Notophthalmus adult brain, under the control of 
dopamine (Berg et al., 2011; Kirkham et al., 2014). In paper III, we present a 
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methodological development that allows for the study of the morphological 
characteristics of ependymoglial cells’ radial extensions. Future work with this 
method may identify additional ependymoglial cell subtypes that play a role in the 
brain maturation processes studied in paper II. 
This study also sheds new light into the neurogenesis of dopaminergic populations 
in the newt brain. Pleurodeles are not only found to have more dopaminergic cells 
in general but also to have a higher number of these cells in males than in females. 
Sexual dimorphism has also been shown in mammals but these results were rather 
opposite, with female mammals having more dopaminergic cells than males, 
except in the olfactory bulb (Abel & Rissman, 2012; Bleier, Byne, & Siggelkow, 1982; 
Gillies, Virdee, McArthur, & Dalley, 2014; Gómez et al., 2007; McArthur, McHale, & 
Gillies, 2007). 
We also find the neurogenesis of specific brain regions to correlate with the 
appearance of specific behaviours and being in accordance to the functions of 
corresponding regions in other tetrapods. For example, we observed an increase 
in the number of dopaminergic cells in the olfactory bulb and that this occurs 
around the time Pleurodeles develop olfaction sensing. At the same time, we also 
detected a neurogenic wave in the ventral/lateral pallia. The lateral pallium in 
mammals gives rise to the olfactory cortex, among other structures. It is therefore 
likely that the neurogenic wave observed in this region in Pleurodeles is also linked 
to the increase in the number of dopaminergic cells in the olfactory bulb (Medina 
& Abellán, 2009). 
In this study, we performed dopaminergic lesioning to investigate the role of 
dopaminergic neurogenesis during development. Our behavioural experiments 
indicated dopaminergic innervation in the striatum and nucleus accumbens to be 
involved in behaviours such as associative learning, decision making and fear. 
Interestingly, in humans the striatum also plays a role in learning and decision 
making (Hiebert et al., 2014), while the nucleus accumbens is involved in fear 
responses (Levita, Dalley, & Robbins, 2002; Martinez, Oliveira, Macedo, Molina, & 
Brandão, 2008). Taken together these observations suggest that many 
neuroanatomically-related behaviours are highly conserved among tetrapod 
evolution. We also demonstrated that lack of dopaminergic innervation in the 
forebrain correlated with lower proliferative activity in this region. This finding is in 
line with studies in primates, where dopaminergic innervation projecting from the 
substantia nigra to the forebrain was found responsible for the stimulation of 
proliferation (Freundlieb et al., 2006). Thus, we once again find brain maturation 
dynamics to be highly conserved in vertebrates. 
* Study limitations 
Some of the limitations of paper II are: 
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§ Labelling by electroporation marks a random fraction of ependymoglial 
cells in the ventricular/subventricular layer of the electroporated brain 
region. These randomly labelled cells can be ependymoglia type-1 or type-
2. In this paper, and to determine characteristics of these ependymoglia, 
we screened for labeled parenchymal cells. A parenchymal cell was 
assumed to have migrated radially and to have arisen from one of its 
nearest radial labelled ependymoglial cells, by using a transgenic line that 
can express a distinctive combination of fluorescent proteins. This is 
because ependymoglia radial projections are oriented in a ventricle-to-pial-
surface fashion. Assuming such origin for parenchymal cells makes sense 
as neuroblasts have been shown to use radial glia (ependymoglia) 
projections as scaffolds for migration (Kawauchi et al., 2010). Based on 
this reasoning we assume isolated labelled cells in the parenchyma arise 
from type-1 ependymoglia (NSC) and grouped labelled cells instead arise 
from type-2 ependymoglia (more frequently dividing 
progenitors). However, as we could not label type-1 or type-2 ependymoglia 
alone we cannot exclude lateral migration to occur during maturation from 
ependymoglia and parenchymal cell stage. If lateral migration would occur 
then the grouped and isolated cells, which are seen in the parenchyma, 
could have migrated from ependymoglia in alternative locations. If this 
would be the case it would be hard to accurately determine the origin of 
the cells and the thus group size.  Although unlikely, this possibility cannot 
be fully excluded without more specific labelling of each of the 
ependymoglia types. 
§ Regeneration of dopaminergic neurons in the ventral midbrain of 
Pleurodeles could be due to developmental compensatory mechanisms 
rather a regeneration response similar to the one  observed in adult 
Notophthalmus brains. 
§ A regeneration response in Pleurodeles brains requires higher proliferation 
(MCM2+) and higher levels of cycling cells (EdU+), in order to replace the lost 
cells. This response also allows for the catch up with the developmental 
processes of dopaminergic cells which are seen in control animals. While 
higher numbers of cycling cells are shown with EdU, higher proliferation 
with MCM2 data is lacking. 
§ The molecular mechanism by which decreased dopaminergic innervation 
leads to lower proliferation levels in the striatum is not elucidated.  
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8.3. Paper III – dopamine and regeneration 
As discussed in chapter 5, available methods for the study of brain cell projections 
are limited by the destruction of the 3D relationship between a sample’s 
components. The aim of this study was to optimize tissue clearing methods for the 
study of dopaminergic neurite outgrowth, as well as of ependymoglia radial 
projections (the progenitors of dopaminergic cells) in the newt brain. These 
methods can aid with the study of the regeneration and development of the 
dopaminergic system. With these methods we hope to be able to answer how long-
range projections between the ventral midbrain and the forebrain are restored in 
the newt brain after the ablation of dopaminergic neurons. 
* Summary of results 
We first asked whether two commonly used tissue clearing techniques, Advanced 
CUBIC and Advanced CLARITY, could be used to image whole developmental and 
adult newt brains. We found both techniques performed sub optimally in these 
small and fragile samples. This was either due to compromising of sample integrity 
in Advanced CUBIC that led to the discarding of a high number of sample replicates 
or due to low resolution and signal intensity challenges in Advanced CLARITY. 
Sample deformation which is induced in newt brains by Advanced CUBIC is 
probably due to the embryonic characteristics of the adult newt brain, as the 
embryonic mouse brain also becomes deformed. Interestingly, adult newt brains 
also become deformed and may retain some of these embryonic characteristics 
and ended up deformed as well. We further reported on the development of a 
flexible and optically optimized method for mounting of fragile and small newt 
brains in light sheet Z.1 microscopes. 
To be able to study small and fragile samples we set out to optimize the Advanced 
CUBIC protocol in order to reduce sample deformation. We achieved this by 
replacing CUBIC reagent 2 with the RI matching solution Omnipaque 350 and by 
shortening all the clearing and staining times within the original protocol. 
Additionally, we reduced the reagent volumes required for achieving clearing of 
each sample. We demonstrated this optimized protocol to retain sample integrity 
of newt brains and denoted it CUBICembryonic (CUBICe). When compared with 
Advanced CLARITY, CUBICe excels at depth, contrast and signal intensity of 
imaging in stained samples. Moreover, transgenic GFP+ expressing newt brains, as 
opposed to stained samples, could also be imaged with this technique. 
By joining CUBICe with electroporation methods for genetic labelling we showed 
it capable of tracing long range projections, dopaminergic fibres and 
characterization of ependymoglial cells. Specifically, we found morphological 
differences between ependymoglial cells of the forebrain by measuring the 
following parameters: the degree of branching, the projections’ total length, the 
distribution of distances from each projection origin to the respective terminal and 
Sholl intersections. In terms of long range projection tracing, we achieved a 
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maximum traced distance of 3647 µm. Lastly, the neurites of one ventral midbrain 
dopaminergic cell were also successfully traced with CUBICe. 
Our main objective with applying tissue clearing methods to the newt brain was to 
study dopaminergic neurites and their cell bodies across the ventral midbrain-to-
striatum region. We found that, in Advanced CLARITY cleared tissue, the ventral 
midbrain dopaminergic cells and their neurites were not clearly visible. However, 
in CUBICe cleared tissue these structures were clearly discernible. We then 
performed dopaminergic lesion in newt brains by injection of 6-OHDA (Parish et 
al., 2007). Then, these brains were cleared using CUBICe. We were able to 
successfully quantify the degree of dopaminergic lesion in midbrain and forebrain 
regions by both contrast and intensity measurements. This demonstrates that 
CUBICe, coupled with bioinformatics pipelines and light sheet microscopy, is an 
easily applicable method for the quantification of dopaminergic lesions in the newt 
brain. We further achieved contrast quantification of the midbrain and forebrain 
regions 30 days after dopaminergic lesion, in the same newt species 
(Notophthalmus viridescens) which was, in a previous study, shown to regenerate 
the ventral midbrain dopaminergic cell bodies. Due to lack of a sufficient number 
of experimental animals we relied on previous investigations which showed full 
dopaminergic cell body regeneration after 6-OHDA lesion is attained at this time 
point (Parish et al., 2007). We found no difference in dopaminergic neurite and cell 
body contrast between control and lesion groups in the forebrain region. However, 
in the midbrain we detected a slight excess of fibres than in the control group, 
which could represent a compensatory mechanism to the performed lesion. 
* Discussion 
As far as we know, no tissue clearing protocol has previously been fine tuned to 
the amphibian and the dissected embryonic mouse brain. However, a whole-mount 
method for imaging of the newt spinal cord already exists but it is limited by lack 
of quantification and the thickness of the tissue that can be imaged (Zukor, Kent, & 
Odelberg, 2010).  
CUBICe is a method that makes it possible to image whole cleared newt brains in 
high resolution without sacrifices in sample fragility and loss. Furthermore, its 
protocol is faster and uses less reagents than the method it was initially based on, 
Advanced CUBIC. Using CUBICe one can quantify dopaminergic lesions and 
subsequent regeneration in regions of the newt brain. A previous study has studied 
axonal regrowth in the optical nerve of zebrafish by resourcing to tissue clearing 
methods (Diekmann et al., 2015). Future work using CUBICe will likely focus on 
studying the targets of regenerated dopaminergic neurites as well as the 
projection differences between regenerated and control dopaminergic neurites. 
By applying CUBICe to newt brains, it is possible to perform neurite tracing to 
distances over 3600 µm. The cells traced in this study were genetically labelled by 
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electroporation. This is a transient method where the labelling intensity becomes 
diluted over repeated cell divisions and becomes, therefore, increasingly hard to 
detect. In future experiments we intend to make use of transgenic lines to stably 
and conditionally label these cells in a long term, non-intensity-dilutable manner 
(Joven et al., 2018). The use of neuronal tracing dyes is another method that can 
be employed in the labelling of brain cells and their corresponding neurites. Many 
neuronal tracing dyes are lipophilic and are therefore incompatible with tissue 
clearing methods which work by facilitating lipid removal from samples. However, 
recent studies have identified some of these dyes to be compatible with tissue 
clearing (B. Hou et al., 2015; M.-T. Ke, Fujimoto, & Imai, 2013; Launay et al., 2015) 
by, for example, binding to both cell membranes and proteins and being aldehyde-
fixable (Kristian H.Reveles Jensen & Berg, 2017). Such a methodological approach 
for the direct labelling of neuronal cells is promising but the injection of these 
compounds in the newt brain is challenging due to the small brain size and the 
unavailability of stereotaxic brain coordinates. Despite these difficulties, some 
studies have achieved the use of these dyes in the newt brain to inform on the 
ventral midbrain-to-striatum dopaminergic pathways (Oscar Marín, González, et al., 
1997a, 1997b; Oscar Marín, Smeets, et al., 1997). 
In this study we were also able to trace several morphological parameters of 
ependymoglial cell radial projections, such as the degree of branching and their 
projection targets. Future studies should focus on the correlation of these 
morphological features with the gene expression patterns that are representative 
of these two types of ependymoglial cells, in the brain of the Notophthalmus 
viridescens newt (Kirkham et al., 2014). The undertaking of such work could also 
further the study of ependymoglia maturation (paper II) by possibly uncovering 
new ependymoglial cell types corresponding to progenitor transit amplifying 
populations which are pre-committed to the genesis of a specific cell type, such as 
dopaminergic neurons. Ependymoglial cells give rise to regenerated ventral 
midbrain dopaminergic neurons as well as other cell types in the newt (Parish et 
al., 2007). Furthermore, radial glial cells, the mammal counterpart of ependymoglial 
cells in the newt, were found to provide a scaffold which aids neuroblast migration 
and promotes neuronal regeneration in the mouse neonatal cortex (Jinnou et al., 
2018). Therefore, the regeneration of ventral midbrain dopaminergic neurons in the 
newt brain could follow the signalling cues of an ependymoglial radial projection 
network and the identification of different ependymoglial cell types can help with 
the understanding of how these processes work. 
* Study limitations 
Some of the limitations of paper III are: 
§ The number of cells which develop to be positive for dopaminergic and 
genetical labelling markers (TH+/GFP+) in the ventral midbrain is very low. 
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Therefore, a substantial amount of animals is required to achieve labelling 
and subsequential tracing of these cells. 
§ The labelling of cells genetically marked through electroporation becomes 
diluted as cell divisions take place. This limits the undertaking of long-term 
labelling experiments. 
§ Due to lack of sufficient number of animals during the regeneration 
experiments we were not able to assess the degree of the lesion. Also for 
the same reason we have only three animals per control and lesion group. 
Given the inherent variability between samples this limits the power of our 
experimental interpretation. 
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9. Conclusions 
This thesis highlights the diverse and complex roles of dopamine in development, 
regeneration and disease.  
In development, dopamine controls proliferation of progenitor cells which is 
indirectly responsible for the later development of specific behaviours. 
In regeneration, dopamine’s role revolves around the maintenance of a quiescent 
state in progenitor cells, some of which are capable of regenerative responses. 
In disease, manipulation of dopamine signalling might be a treatment option for 
glioblastomas. Further investigations could reveal to what extent endogenous 
dopamine signalling influences glioblastoma growth in the brain. Furthermore, 
dysfunction of dopamine signalling is one of the hallmarks of Parkinson’s disease. 
Specific conclusions for papers I-III are: 
I. Trifluoperazine, a dopamine receptor 2 antagonist, inhibits growth and 
proliferation of glioblastoma cell lines, indicating the possibility of using 
dopamine receptor signaling pathways as targets for pharmacological 
interventions. 
II. During developmental maturation, the newt brain exhibits distinct features 
and substantial similarities among closely related species. This 
developmental map constitutes the groundwork for finding molecular keys 
behind the salamanders’ capacity for brain regeneration. 
III. CUBICe is a superior method to other currently available protocols for the 
study of neurites and fibres in the developmental and adult newt brains. It 
allows for tracing of neurons and other brain cells and specifically the 
quantification of dopaminergic innervation after ablation and subsequent 
regeneration. 
In the words of the great neuroscientist António Damásio4, “we almost never think 
of the present, and when we do, it is only to see what light it throws on our plans 
for the future”. Indeed, the discussion of the present work leads us into considering 
the future developments in this field. From my perspective, the holistic view of one 
single researcher working on his/her own and thereby bringing breakthrough 
                                                   
4 “Descartes' Error: Emotion, Reason and the Human Brain” (2006), ISBN 978-0099501640. 
These exact words are paraphrased by António Damásio from a text whose authorship is 
originally attributed to Blaise Pascal. 
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scientific discoveries to the eyes of the scientific community is long gone. The 
methods utilized in answering the research questions in this field, such as the ones 
in this thesis, profoundly and constantly increase in complexity and cost. It is 
perhaps acceptable to say one laboratory is not enough. We should disengage 
from working in our own bubbles and, instead, establish strategic and effective 
collaborations so that new scientific grounds can be reached and explored more 
rapidly. Papers I and III in this thesis are a result of successful inter-laboratory 
collaborations, with the Chemical Biology Consortium Sweden and the National 
Microscopy Infrastructure, respectively. These provided both essential knowledge 
and technology, that were critical for answering the questions we set out in these 
projects. 
As a final note, the brain is a marvellous structure filled with all kinds of secrets and 
riddles. Having had the opportunity to study it and in this manner unravel little 
pieces of its mysteries has been a true privilege. Until we meet again. 
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